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ABSTRACT 
 
 
 Despite the huge palette of the existing intestinal models, the drug development 
industry is not entirely satisfied since these models poorly replicate the architecture and 
mechanisms occurring in a living tissue. The current understandings on a number of biological 
processes are based on two-dimensional (2D) surfaces however in vivo cells primarily exist in 
a heterogeneous and information-rich environment which modulate a diversity of cellular 
events. The 2D models are a reductionist approach that not faithfully captures the in vivo 
scenario. In fact, the striking similarity between the in vivo morphology and behaviour of 
cells in tridimensional (3D) culture conditions, have turn 3D models in a mainstream 
approach.  
The present study extends a traditional intestinal model to the deeper layers of the 
small intestine, in particular the intestinal mucosa that includes a broad variety of stromal 
cells. Fundamentally, this work aimed to dissect the stromal-epithelial interactions and 
evaluate the permeation of a protein drug, insulin, using a 3D based model comprising CCD18-
Co intestinal myofibroblasts embedded in Matrigel, Caco-2 and HT29-MTX epithelial cells and 
Raji B lymphocytes. 
 As the 3D environment triggers different cellular responses of the 2D environment, the 
density of CCD18-Co cells was optimized and the results showed that 1×104 cells/cm2 was the 
cell density better adapted to 21 days of culture, period necessary to fully differentiate Caco-
2 cells. CCD18-Co cells embedded in Matrigel showed to exert a supportive role in the 
maintenance of the epithelial cells onto them. This structure is similar the native intestinal 
mucosa architecture. Matrigel, primarily acting as an initial livelihood, was substituted by 
extracellular matrix components newly produced by CCD18-Co cells. 
 All the studied models revealed functionally effective, returning sustainable results of 
transepithelial electrical resistance and expression of tight junction (TJ) proteins, which are 
indicators of membrane integrity and tightness respectively. Although Caco-2 cells form tight 
junctions between them, the introduction of mucus-producing HT29-MTX cells interferes with 
the tightness of the barrier due to structural differences between the TJs.  
 As mean to explore the transcytotic capacity of M cells, Raji B lymphocytes were added 
to the basolateral side of the Transwell insert to carry out the phenotypic conversion of Caco-
2 cells into M-like cells. Although trigger these cells is a challenge due to the inexistence of a 
distinct cell marker, the lack of microvilli was the best cue to identify M-like cells. 
The 3D quadruple model showed to be efficient in the prediction of insulin 
permeability. The less tight junctions between the epithelial cells, the existence of mucus 
and the presence of M-like cells were critical factors in the transport of insulin.  
Ultimately, this model closely resembles the intestinal mucosa representing a 
sophisticate and robust tool useful in the absorption’s evaluation of incoming drugs in the 
market. 
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RESUMO 
 
 
 Apesar da existência de uma grande palete de modelos intestinais, a indústria de 
desenvolvimento de novos fármacos não está inteiramente satisfeita, uma vez que estes 
modelos não replicam plenamente a arquitetura e os mecanismos existentes num organismo. 
A atual compreensão de muitos processos biológicos é baseada em superfícies bidimensionais 
(2D), no entanto, in vivo, as células estão rodeadas por um ambiente heterogéneo e 
informativo que modula uma diversidade de eventos celulares. Os modelos 2D são uma 
abordagem reducionista que não captura fielmente o cenário in vivo. Na verdade, a 
semelhança notável da morfologia e comportamento in vivo em condições de cultura 
tridimensional (3D) tem tornado os modelos 3D a principal abordagem.  
 O presente estudo estende um modelo intestinal tradicional para as camadas mais 
profundas do intestine delgado, em particular a mucosa intestinal, que inclui uma ampla 
variedade de células do estroma. Fundamentalmente, este trabalho visou dissecar as 
interações estroma-epitélio e avaliar a permeação de um fármaco proteico, a insulina, usando 
um modelo 3D composto por miofibroblastos intestinais CCD18-Co embebidos em Matrigel, 
células epiteliais Caco-2 e HT29-MTX e linfócitos Raji B. 
 Como o ambiente 3D desencadeia diferentes respostas celulares do ambiente 2D, a 
densidade de células CCD18-Co foi otimizada e os resultados demonstram que 1×104 
células/cm2 foi a densidade celular melhor adaptada aos 21 dias de cultura, período 
necessário para diferenciar totalmente as células Caco-2. As células CCD18-Co embebidas em 
Matrigel mostram exercer um papel de suporte na manutenção das células epiteliais. Esta 
estrutura é semelhante à arquitetura nativa da mucosa intestinal. Matrigel, que inicialmente 
atuava como um meio de vida, foi substituído por componentes da matriz extracelular recém 
produzidos pelas células CCD18-Co. 
  Todos os modelos estudados se revelaram funcionalmente eficazes, devolvendo 
resultados sustentáveis de resistência transepitelial e expressão de junções apertadas, que 
são indicadores de integridade e estreiteza da membrana, respetivamente. Apesar das células 
Caco-2 estabelecerem juncões intercelulares entre elas, a introdução das células HT29-MTX 
produtoras de muco interfere com a estreiteza da barreira devido às diferenças estruturais 
existentes entre as junções.  
 Como meio de explorar a capacidade transcitótica das células M, linfócitos Raji B foram 
adicionadas na parte basolateral do Transwell insert para conduzir a conversão fenotípica das 
células Caco-2 em células do tipo M. Embora detetar estas células seja um desafio devido à 
inexistência de uma marcador distinto, a falta de microvilosidades foi a melhor pista para 
identificar as células do tipo M. 
 O modelo quádruplo 3D mostrou ser eficiente na previsão da permeabilidade da 
insulina. O carácter menos apertado entre as células epiteliais, a existência de muco e a 
presença das células M foram fatores críticos no transporte de insulina.  
 vi 
 
 Para finalizar, este modelo assemelha-se à mucosa intestinal, representando uma 
ferramenta sofisticada e robusta útil para a avaliação da absorção de novos fármacos que 
chegam ao mercado. 
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1.1. Intestinal and mucosal functioning 
 
  Intestine is the major portion of gastrointestinal (GI) tract whose primary function is 
to gather the entrance of pathogens, toxins and undigested molecules while enabling the 
digestion and selective absorption of essential nutrients into the body. These distinct 
functions place the intestinal mucosa in the center of interactions between the immune 
system and the luminal contents [1].  There is no doubt that there is a tight control of enteric 
bacteria population and the luminal contents presenting those components to diverse physical 
and chemical intestinal barriers. If the foremost barriers fail, immune cells (phagocytes and 
lymphocytes underlying the lamina propria) are the next in line to carry out defensive actions 
[2].   
 Human small intestine, owing the larger surface area provided by valves of Kerckring 
(macroscopic valve-like folds), villi (finger-like protrusions), crypts (finger-like invaginations) 
and microvilli (cytoplasmatic extension), represents the protagonist organ in the drug 
absorption [3]. Absorption evaluation plays an ever increasingly role at the early stages of 
drug discovery due to its colossal potential to eliminate molecules with poor ADME 
(Absorption, Distribution, Metabolism and Excretion) properties from the drug development 
pipeline. Therefore, the replication of the intestinal functioning has revealed an attractive 
strategy that will potentially energize the drug development.  
 
1.2. Intestinal progeny 
 
 The intestinal epithelium is unique in the cell proliferation, differentiation and 
apoptosis mechanisms as it occurs in an orderly fashion along the crypt-villus axis but ceases 
as cells reach the apex of villi ongoing spontaneous apoptosis and detaching into the lumen 
[4]. Wnt signal transduction pathway is the primary driving force behind intestinal 
proliferation responsible for maintain the crypt cell population in proliferative state [5, 6]. 
Proliferative crypts are monoclonal compartments [7] that harbour intestinal epithelial stem 
cells (IESC) and their progeny - transit-amplifying cells – partially differentiated cells that 
divide 4-5 times before terminally differentiate (Fig. 1.1 A). The differentiated cells 
generated from this process are divided in two populations that holds absorptive enterocytes 
and secretory cells including goblet, enteroendocrine and Paneth cells (Fig. 1.1 B) [5]. 
Although most reviews are focused on the aforementioned four cell types, there are 
described three additional intestinal cell types including microfold cells (M cells) [8], tuft 
cells or brush cells [9] and cup cells [10]. 
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Figure 1. 1. Intestinal cells lineage in mammalian small intestine. Migratory process of transit-amplifying cells 
occurs in an orderly fashion along the crypt-villus (A) given origin to four main cell types classified according 
absorptive or secretory cells (B). Adapted from Crosnier C. et al. [4]. 
  
 
 Absorptive enterocytes, representing about 80% of intestinal epithelial cells [11], are 
columnar and polarized cells discernible by the presence of apical brush border relevant in 
nutrient absorption. Goblet cells, scattered throughout the epithelium, are responsible for 
the secretion of protective mucins and trefoil factors (TFF) required for the movement and 
expulsion of gut contents and provide protection against shear stress and chemical damage. 
Enteroendocrine cells, about ~1% of epithelial cell population, represent a bridge between 
the central and enteric neuroendocrine system throughout the secretion of peptide hormones 
[12]. Paneth cells, with a function in innate immunity [13], are the only differentiated cells 
that reside on the undifferentiated compartment of intestinal mucosa, the crypts. These cells 
are usually identified by the large apical secretory granules that contain lysozymes, 
antimicrobials proteins (AMPs) and defensins [14]. Collectively, the diverse functions of 
intestinal epithelial cells result in a dynamic barrier that maintains the segregation between 
the luminal microbial communities and the mucosal immune system (Fig. 1.2) [12].  
 Overall, intestinal stem cells, their progeny and their microenvironment make up the 
niche, an anatomical and functional structure that coordinates the normal homeostatic 
production of functional mature cells. An intimate regulation between intrinsic and extrinsic 
cellular mechanisms maintains the balance between self-renewal and differentiation events 
[7]. 
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Figure 1. 2. The regulatory barrier function of intestinal epithelial cells. AMPs and TFF, respectively secreted by 
goblet and Paneth cells, promote the exclusion of bacteria from the epithelial surface. The luminal release of 
secretory IgA (sIgA) protects the intestinal epithelium from enteric toxins and pathogenic microorganisms. M cells 
mediate the transport of luminal antigens and bacteria across the epithelial barrier for immunological surveillance. 
Adapted from Peterson L. and Artis D. [12].  
  
1.3. Intestinal immunology 
 
 Despite the selective character provided for highly efficient barriers, some pathogens 
can overcome the protective mechanisms and enter in the systemic circulation. As an extra-
protective effort, the intestinal lining has more lymphoid cells and produces more antibodies 
than any other organ in the body [15]. The complex interplay of regulatory systems ensures 
the maintenance of gut homeostasis allowing the clear discrimination between invasive 
organisms and harmless antigens. Indeed, an active immunity against non-pathogenic 
materials and hypersensitivity against dietary antigens and commensal bacteria can unroll in 
inflammatory disorders such as coelic disease and Crohn’s disease, respectively [1]. 
 Every mucosa region in the body has their own region for immunological surveillance 
known as mucosa-associated lymphoid tissue (MALT), with similar but not identical cellular 
composition [16]. The intestinal immune responses are entrusted to gut-associated lymphoid 
tissue (GALT), which tasks are divided for induction sites consisting of PPs and mesenteric 
lymph nodes (MLNs), involved in the induction phase of the immune response [2, 17] and 
effector sites that are diffused throughout the lamina propria and the epithelium of the 
mucosa [15]. Both the PPs and the villus are drained by afferent lymphatic that go to MLNs [1] 
(Fig. 1.3). 
PPs have been increasingly valued since they are considered the immune sensors of 
intestine [18]. They are macroscopic lymphoid aggregates found in submucosa surrounded by 
a single layer of columnar epithelial cells, the follicle-associated epithelium (FAE), an 
interface between GALT and the luminal environment [18]. Mature PPs generally consists of 
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collections of large B-cell follicles and intervening T-cell areas [1]. Added to that, FAE is 
considered a selective break of intestinal barriers due to the lower levels of digestive 
enzymes, a less pronounced brush border surface and mucus production in reduced 
quantities, facilitating the access to the apical surface [18].  
 
 
Figure 1. 3. Intestinal sites of immune response. The lymphoid areas are separated from the intestinal lumen by 
FAE and a more diffuse area below the epithelium known as subepithelial dome (SED). Adapted from Mowat A. [1]. 
  
 
1.3.1. M cells associated to lymphoid tissues 
 
 FAE’s most determinant feature is the presence of M cells, specialized enterocytes for 
antigen sampling that constitute 10% of epithelial cells of the FAE [19]. However they 
represent a ratio of 1 in 10 million to the total number of intestinal epithelial cells [20]. 
These cells are highly specialized for the phagocytosis and transcytosis of luminal content, 
particularly antigens and pathogenic or commensal microorganisms [21, 22]. Beneath the M-
cell basolateral membrane, antigens are taken up by intraepithelial pocket which contains a 
population of lymphocytes and mononuclear phagocytes (a heterogeneous population of 
macrophages and classical DCs) (Fig. 1.4 A) [8]. 
 Morphologically distinct from enterocytes, M cells display poorly organized brush border 
with short irregular microvilli at the apical domain (Fig. 1.4 B), usually identified by 
immunostaining of actin and villin [23]. The usual thick glycocalyx of absorptive cells is 
replaced in M cells by a thin glycocalyx. Naturally, these features lead to a highly attenuated 
expression of apical digestive enzymes such as alkaline-phosphatase and iso-sucrase maltase 
[20, 24]. 
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Figure 1. 4. Morphological features of M cells. (A) M cell features denoting the lack in microvilli and mucus layer 
and the basolateral pocket containing immunosurveillance cells. (B) Scanning electron microscopy of M cell 
highlighting the blunted microvilli. (C) Immunohistochemical analysis of mature M cells in the FAE of a mouse PPs of 
specifically expressing glycoprotein 2 (GP2). Adapted from Mabbott N. A. et al. [8]. 
  
 The reduced brush border and lack in enzymatic activity clarifies the inexistence of a 
prominent role of M cells in digestion or absorption. On the other hand, the exposed nature of 
M cell apical surface and their location sited over lymphoid follicles assuring the immediate 
exposure of foreign matter to underlying immune cells, points the transepithelial transport as 
the primary function of M cells [24]. 
 Due to the lack of knowledge, general agreement on M cell function fails to go further 
than this, but, at least, M cells express a variety of “immunosurveillance” receptors on their 
apical surfaces that enable them to sample diverse microbial pathogens and antigens such as 
glycoprotein 2 (GP2), uromodulin (UMOD) and cellular prior protein (PrPC), among others [8, 
19, 25]. 
 
1.3.1.1. M cell differentiation in the gut epithelium  
 
  In the intestine, the dome-associated crypts surrounding the FAE and the villous 
crypts at the base of the villi contain cycling Lgr5+ cells (leucine-rich repeat-containing G 
protein couple receptor) intermingled among Paneth cells, from each almost epithelial cells 
lineage, including M cells, emerged (Fig. 1.5, A) [26]. As both dome associated crypts and 
villous crypts contain cycling Lgr5+ stem cells, additional signals from the stromal and immune 
cells in the SED are required to induce M cell differentiation. In intestine, the cytokine 
Receptor Activator of NF-kB Ligand (RANKL) is selectively expressed by the subepithelial 
stromal cells beneath the FAE (Fig. 1.5, B) [8]. Analysis of a RANKL-deficient mice and 
administration of exogenous RANKL in vivo reveals that this cytokine is a critical factor that 
controls the differentiation of RANK-expressing enterocytes into M cells. Indeed, the 
interaction between RANKL and its receptor RANK will induce Spi-B (transcription factor) 
expression that could induce the maturation of M cells (Fig. 1.5, C) [27, 28]. 
B 
C 
A 
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 M cell phenotype can also be induced by immune cells attracted to the dome region by 
the cytokine CCL20 produced by epithelial cells (Fig. 1.5, D) [29]. Immune cells interact with 
CCL20 through their receptor CCR6, verifying that when this signalling is impeded, M cell 
maturation is likewise compromised [30]. However, CCL20-CCR6 signalling does not influence 
the initial M cell differentiation but instead hampers their functional maturation [31]. 
Therefore, the remaining question of how B cell interacts with M cells precursors is not fully 
clarified but some authors claim that CD37L-CD37 signalling between M cells progenitors and 
the basolateral pocket of B cells may provide at least one of the signals that induce final 
functional maturation [32].  
  
  
Figure 1. 5. Possible mechanism behind M-cell genesis derived from Lgr5+ stem cells in the crypts. (A) All the 
epithelial cell lineages develop from Lgr5+ intestinal stem cells located in the crypts. (B) RANKL is selectively 
expressed by the subepithelial stromal cells beneath the FAE. (C) The RANKL-RANK interaction will induce Spi-B 
expression that could induce the maturation of functional M cells. (D) Immune cells can also induce M cell 
phenotype attracted to the dome region by the cytokine CCL20 produced by epithelial cells. Adapted from Mabbott 
N. A. et al. [8]. 
 
1.3.1.2. In vitro M cell differentiation 
  
 The FAE that overlies Peyer’s Patches constitutively expresses the chemokine CCL20 
that is not expressed in the absorptive epithelium [33]. However the mechanisms behind the 
interplay between FAE differentiation and CCL20 expression are poorly understood. At the 
same time, lymphotoxin β receptor (LTβR) signalling plays a central role in the PPs’ 
organogenesis [34, 35]. Taking together this events, Rumbo et al. studied whether LTβR 
mediates the CCL20 gene expression in intestinal epithelial cells. The results demonstrate in 
vivo and in vitro evidences that LTβR signalling may be responsible for the CCL20 production  
[33]. 
 Other in vitro studies showed that lymphocytes trigger the conversion of enterocytes 
cell lines into M-like cells in co-culture under influence of membrane-bound lymphotoxin 
(LTα1β2) secreted by B-lymphocytes. However, in vivo M cell differentiation reveals that the 
absence of mature lymphocytes does not prevent the formation of M cells indicating that 
signalling molecules that support M cell differentiation, such as lymphotoxin, may be supplied 
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by other underlying cells. Notwithstanding, mature lymphocytes are required for the 
formation of full-sized FAE [36]. 
 It is still controversial whether M cells arise as a separate cell line or differentiate from 
enterocytes on the dome under the influence of immune cells [37, 38]. 
 
1.4. Epithelial - mesenchymal crosstalk 
 
 The function of the intestinal stem cells is to maintain the integrity of the intestinal 
epithelium. Stem cells dynamics are regulated by environmental factors, the sum of which 
constitutes the protective niche composed by neighbouring epithelial cells, mesenchymal 
cells, basement membrane (BM) and soluble cell- or matrix-associated growth factors [39]. It 
is established that although separated from the epithelial cells by the basement membrane, 
the constellation of mesenchymal elements promote the epithelial-mesenchymal crosstalk 
required to maintenance of the physiological homeostasis and the stem cell niche [40]. 
 During the past decade, the permissive and instructive actions of the mesenchyme in 
the epithelial cells have been highlighted by the expression of important growth factors 
whose receptors are found on the epithelial cell surface, for instance, HGF/SF4 (hepatocyte 
growth factor/scatter factor) and KGF (keratinocyte growth factor) which regulate the 
epithelial cell behaviour [41].  
 
1.4.1. Epithelial - stromal interface 
 
 As in most of the tissues, intestinal epithelium is supported by BM that separates 
epithelial cells from subepithelial fibroblasts or intestinal myofibroblasts (IMFs). IMFs are 
defined by phenotypic characteristics of both fibroblasts and smooth muscle cells [42]. They 
express α-smooth muscle actin (α-SMA), intermediate filaments such as vimentin but very 
weakly positive or negative for desmin and the absence of epithelial cytokeratins [43, 44] 
(Table 1.1). Although various combinations of these markers have been used to demonstrate 
the plasticity of IMFs, they are defined by their location and structure together with the 
expression of α-SMA, the best single but not absolutely exclusive marker [39].  
 
Table 1. 1. Mesenchymal stromal cell markers. Adapted from Pinchuk I. V. et al. [43]. 
            CELLS 
MARKERS 
Myofibroblasts Fibroblats Pericytes Muscularis mucosae 
α-SMA + - + + 
Desmin - - ± + 
Vimentin + + + - 
CD90 + + + ± 
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 IMFs have flattened cell bodies, constituting a cellular network that ensheaths the 
lamina propria of the intestinal villi.  In the small intestinal villus, α-SMA staining of 
subepithelial cells is less than those surrounding the crypts, and may even be lost all together 
in the mid- and upper villus [45]. Subepithelial cells stain weakly for desmin, suggesting the 
existence of α-SMA cells in the intestinal villus such as pericytes (mural cells that surround 
the capillaries of the lamina propria) [46]. Originally believed to be restricted to a two-
dimensional (2D) network along the villi, IMFs are actually connected to α-smooth negative 
fibroblasts-like cells and pericytes forming a tridimensional (3D) network [47, 48] (Fig. 1. 6). 
 
Figure 1. 6. Stromal-epithelial interactions along the villus-crypt axis. (A) Detailed interactions between IMFs 
that ensheaths the lamina propria and pericytes that support the capillaries. (B) Cross section through the intestinal 
villus with positive (brown) α-SMA IMFs. (C) Cross section through the crypts demonstrating the IMFs connected to 
the muscularis mucosae (thick red arrows) at the bases of the crypts. (D) PPs with its vascular, lymphatic and 
stromal elements, except lymphocytes, macrophages and dendritic cells.  Adapted from Powell D. W. et al. [39, 
42]. 
  
 Several evidences state that the interaction between myofibroblasts and epithelial cells 
reveals truly important in supporting mucosal architecture and development but also the 
stem cell niche. IMFs have been associated to stem cell regulation proven to be necessary to 
the successful engraftment and proliferation of enteroids (intestinal crypt cultures) [49]. 
Although, these regulation is not clear due to the multiple factors and cell types known to be 
involved in stem cell regulation.  
 Additionally, IMFs are likely to play supportive roles promoting epithelial regrowth and 
enhancement of barrier function during time of injury throughout subepithelial myofibroblasts 
migration [50]. Likewise, the absence of myofibroblasts precluded the successful maintenance 
of epithelial cell formation and proliferation, even under the presence of supportive growth 
factors [51]. Tissue repair-associated factors such as TNF-α, IL-1, IL-2, IL-6 and IL-15 activate 
myofibroblasts causing their motility and release of ECM components and growth factors. On 
the other hand, pro-inflammatory cytokines and growth factors control the expression of 
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matrix metalloproteinase (MMPs) and TIMP (specific inhibitors of MMPs) contributing to the 
tissue remodelling [48]. 
   
1.5. Intestinal barriers 
 
 The magnitude of interactions with the external environment reaches a pinnacle in the 
GI tract, the largest mucosal surface in continuous contact with dietary antigens and 
microorganisms. Before the immunological surveillance by the underlying immune cells, 
foreign organisms are exposed to protective barriers that will counteract absorptive events 
[52] (Fig. 1. 7).  
  
 
Figure 1. 7.Sequential barriers during the transit of a drug molecule in the GI tract when orally administered 
until reaches the systemic circulation. Adapted from Chen M. et al. and Artursson P. et al. [53, 54]. 
 
1.5.1. Luminal barriers 
 
 The drastic pH changes in stomach from slightly acid (pH 1.2 - 3.0) to slightly basic (pH 
6.5 – 8.0) in the proximal end of ileum impact the drug stability and solubility [15]. Beyond 
small intestine being the major place of absorption, the enzymatic activity gathers a big 
palette of proteolytic enzymes divided in three classes: luminal, membrane-bound and 
cytosolic proteases. Oral administered compounds undergo proteolytic degradation in 
stomach by pepsin [55]. Upon reaching the duodenum, luminal proteases secreted by 
pancreas and released in the small intestine, namely serine endopeptidase, trypsin, α-
chymotrypsin, elastase and exopeptidases (carbopeptidases A and B), degrade the mixture of 
peptides and proteins. They are digested further by membrane-bound (brush-border) and 
cytosolic proteases (cytoplasm and lysosomes) associated to enterocytes. Proteases in the 
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brush border of enterocytes are potential the most biologically active enzymatic barrier, 
accounting with membrane-bound proteases and pancreatic enzymes that may be adsorbed 
from the luminal fluid [55, 56].  
 Apart from that, the aminopeptidases in PPs are about 20-30% of the neighbouring 
areas reinforcing that the unprotected FAE of PPs is potential targeting site for proteins 
delivery [57]. 
 As the most abundant class of antibodies found in the intestinal epithelium, secretory 
IgA (sIgA) has been recognized as a first line defence in protecting the intestinal epithelium 
from enteric pathogens and toxins [58]. The production of sIgA is dependent on the sampling 
by M cells from PPs processing a pallet of antigen-presenting cells and multiple cytokines. 
sIgA operates in the clearance of antigens and pathogenic microorganisms from the intestinal 
lumen by blocking their access to epithelial receptors, a process known immune exclusion 
[59].   
 
1.5.2. Gut wall barriers 
 
 Beyond the luminal barriers, the gut wall barriers are equally challenging consisting of 
mucus layer, the epithelium equipped with tight junctions and efflux transporters and 
metabolizing enzymes. 
 The entire intestine is covered by a stagnant layer composed by water, mucus and 
glycocalyx adjacent to the intestinal wall that is permeable to nutrients, water and small 
molecules but restrict to bacteria and pathogens [60] . Mucus secreted by the epithelial cells 
throughout the gastrointestinal tract has a unique secretion that forms a gel adherent to the 
surface constituting a protective wall. However, mucus layer is responsible by a rapid particle 
clearance due to the quick turnover, approximately 2-5 days in the small intestine of humans, 
preventing drug penetration and consequent absorption [61]. Additionally, the repulsion 
between drugs and the negatively charged mucus obstruct the direct contact between those 
drugs and the epithelial cells [62]. Even though all the limitations that mucus represents, its 
hydrogel-like structure reduces the shear stress and can stick a compound in the firmly 
adherent mucus layer increasing the transcellular migration into the epithelial wall [63]. 
The second rate-limiting step to absorption is the epithelium reinforced by tight 
junction and efflux transporters. Epithelial barrier is regulated by junctional complexes 
referred as tight junctions (TJs), adherent junctions (AJs), desmossomes and gap junctions. 
TJs between the neighbouring cells exclude the influx bacteria and molecules larger than 200 
Da through paracellular routes [53] together with efflux transporters that forward unwanted 
substances back to the lumen. P-glycoprotein (P-gp) is the most studied member of multidrug 
resistance (MDR) family, primarily expressed on the apical membrane of the epithelial cells 
[64]. It reduces the intracellular accumulation or  transcellular translocation of many 
compounds [65]. The combined role of P-glycoprotein with cytochrome P450 (CYP) 3A drug 
INTRODUCTION  
 
11 
 
metabolizing enzyme has been recognized as a major determinant of gut wall absorption [66, 
67]. 
 Finally, even if a significant amount of drug is transported through the intestinal 
epithelium, the first-pass metabolism by liver will highly reduce the dose fraction that 
reaches the systemic circulation [68]. Other limiting factors should fall in the scope of 
considerations including fast elimination from the systemic circulation, inducement of an 
immune response, uptake by non-target tissues and an inefficient target cell entry [60]. 
 To overcome these barriers, innovative strategies have been proposed including 
chemical modification, formulation vehicles, proteases inhibitors, absorption enhancers and 
mucus-adhesive polymers [55, 60, 63].  
 
1.6. Intestinal transport mechanisms 
 
The process of absorption involves a set of processes that consists of pre-absorption, 
uptake and translocation and arrival to the destination targets. Molecules cross the intestinal 
epithelium having at disposal five distinct mechanisms: paracellular transport (A), 
transcellular passive transport (B), transcellular active transport or carrier mediated 
transport (C), receptor-mediated transcytosis (D) and via M cells of PPs (E), represented in 
Fig. 1. 8 [69].  
 
 
Figure 1. 8. Schematic representation of mechanisms of transport. (A) Paracellular transport; (B) Transcellular 
transport; (C) Carrier-mediated transport; (D) Receptor-mediated transport; (E) M-cell mediated transport by 
phagocytosis. Adapted from Yun et al. [55]. 
 
1.6.1. Paracellular pathway 
 
Starting by the paracellular route, small hydrophilic particles may elect this route or 
the aqueous route that normally absorbs nutrients or vitamins [15], using the intracellular 
spaces between the epithelial cells (Fig. 1.8 A). This route is used by hydrophobic molecules 
such as oxygen and carbon dioxide that are small or neutral in charge and can cross the 
epithelial layer by uninhibited diffusion [70]. 
At a certain level, this route gained interest for peptide delivery due to the lack in 
proteolytic activity [60] however, the paracellular space represents less than 1% of the 
intestinal mucosa surface contributing for a minimal transport [70].  
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1.6.2. Transcellular pathway 
 
Larger compounds are not able to use intracellular spaces, taking the transcellular 
route passively. Transcytosis or transcellular pathway involves the uptake in membrane-bound 
vesicles by a process named endocytosis at the apical membrane, further released in the 
basolateral membrane (Fig. 1. 8 B) [71]. The endocytic process is divided in phagocytosis 
(uptake of large particles) and pinocytosis (uptake of the fluids and solutes), the last divided 
at least in four basic mechanisms: macropinocytosis, clathrin-mediated endocytosis, caveolin-
mediated endocytosis and clathrin and caveolin-independent endocytosis [72].  
Notwithstanding, most of the therapeutic peptides and proteins are intact absorbed 
and are not expected to follow the transcellular route in a passive way. The active 
transcellular transport of peptides and proteins occurs via a specific carrier (Fig. 1. 8 C) [69]. 
Carrier-mediated pathway is a energy-dependent and saturable mechanism (concentration 
dependent) [73]. The molecule approaches the cell membrane and interacts with the 
transport proteins on the surface of the lipid bilayer forming a reversibly bound. These 
complex cross the lipid bilayer and when reaches the other side of the cell, the bound 
between the molecule and the transport protein is disrupted placing the molecule outside the 
cell [70].  
A select group of macromolecules that are too large to slip through facilitated 
transport pathways and too constrained thermodynamically to transverse a lipid bilayer 
possible, readily moves across the transcellular barrier through receptor-mediated 
endocytosis (Fig. 8 D) [74]. This transport has been explored to increase the oral 
bioavailability of protein drugs by modification of receptor specific ligands with peptide and 
protein drugs. Protein drugs can act either as receptor specific ligands for surface-attached 
receptors or as receptor for surface-attached ligands [55]. This transport entails binding of 
the ligand to a specific cell surface receptor, receptor clustering and internalization [15].  
 
1.6.3. M-cell mediated transport 
 
As previously mentioned, the break in the intestinal barrier of the specialized 
epithelium FAE have been explored as a route of transport (Fig. 1. 8 E) [75]. M cells delivery 
by PPs involves the contact with the projections on M cells surfaces followed by a rapid 
phagocytosis. The fusion of the phagocytic vesicle with the basolateral membrane results in 
the emptying of the vesicle into the intraepithelial pocket. Particles can be engulfed by 
phagocytic cells in the pocket or pass through the basal lamina into the sub-epithelial region. 
Unavoidably, M cells mediated absorption represents an outstanding opportunity for explore 
drug absorption using nanocarriers [76].  
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1.7. Predicting intestinal absorption 
  
 Understanding and anticipating the mechanisms and factors that affect the 
gastrointestinal absorption is of utmost importance in the development and classification of 
new drugs [77]. 
 With view to simplify and speed up the prediction of intestinal permeability, multiple 
screening techniques have been purposed. For many reasons, but particularly due to financial 
and ethical considerations, in vitro models are the most extensively used over the years 
based on Caco-2 intestinal epithelial cells [78]. Inherently, in vitro models raise questions 
about the extrapolation of results to the in vivo scenario. On the other hand, the complex in 
vivo environment difficult data interpretation together with the fact that, the 
microenvironment of a murine has subtle but not no negligible differences compared with in 
vivo circumstances [79].  
 What about artificial membranes and computational-based models? Are they on the way 
to replace Caco-2 models? In the drug development field, in silico, computational and 
mathematical models significantly support decisions about drug absorption in the early 
screening phase of drug evaluation. This power has a huge impact in drug companies, 
reducing the time and the costs in selecting potential candidates and performing the 
biological screening. The efficiency of this approach is recognized by the pharmaceutical 
industry however the insufficient database with reliable information is the major 
impediment. Therefore, the fact that neither the absorption process nor the experimental 
techniques used for data capture are not fully understood, the computational models will not 
do the job better [80, 81].  
 In this subchapter will be highlighted multiple approaches for drug absorption screening 
that reflect the increasingly necessity of predict the intestinal absorption, summarized in 
Table 1. 4 at the end of the subchapter.  
  
1.7.1. In vivo models 
 
 No matter how sophisticated in vitro models are, in vivo evaluation will continue to be 
an invaluable tool required to validate the true performance of a drug or delivery system 
[82].  
 The main advantage of in vivo models is the integration of dynamic components such as 
the mesenteric blood circulation, the mucus layer and other factors that influence drug 
bioavailability [77].  
 In turn, the main weakness of in vivo models is the difficulty in separate the variables 
involved in the process of absorption, which difficult the identification of individual rate-
limiting steps. The impact of anatomical and physiological differences, between and within 
species, influences the choice of the animal model [83]. For instance, the intestinal mucosal 
surfaces are comparable between species but drug transported proteins, enzymes and 
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microorganisms can differ. Rat is the most frequently animal model with similar absorption 
profiles and similar transport expression patterns to the human. However, the distinct 
patterns of metabolizing enzymes mistake the predictions [84]. The evolutionary proximity 
between monkeys and humans put this specie in a special place in drug discovery, however 
the costs and ethical concerns limit their use [77]. Pigs are also used to absorption studies 
due to the similarity of large intestine with human but data is rare [85]. Given these facts, 
has been stated that “the only real model for a man is man” [79]. 
  
1.7.2. In vitro models  
 
 It is been stated that in vitro models do not mimic the real situation, but these models 
cannot be reduced just to that. Cell-based models are a commitment between an 
intermediate level of complexity, with multiple transport systems than reflect the organ in 
vivo and what is feasible to reproduce in the laboratory [77]. In the field of drug discovery 
and development, what may be more relevant is to reproduce the extent and nature of 
transport and metabolising systems observed in the organ in situ, rather than the organ 
specific phenotype. In fact, animal models will always be part of drug development, clearly 
showing the propensity for oral absorption and the limitations that the whole organism offers 
to the absorption of a drug. At this point, in vitro models can sponsor a significant reduction 
of the in vivo models usage, allowing the earlier identification of drug candidates with poor 
ADME properties.  
 Therefore, the key thought is to understand the models limitations and use them as a 
mean to reduce the wastage and the expense of drug administered quantities, as well as to 
allow a more strategic planning of in vivo animal experiments. 
 
1.7.3. Caco-2 based models 
 
 Since their isolation from a human colorectal carcinoma [86], Caco-2 cells have been 
widely used to absorption studies, considered to be the ‘gold standard’ of intestinal 
absorption assays [87]. Caco-2 cells spontaneously undergo typical enterocytic differentiation, 
a process that is growth related. At early stages of culture (3-4 days), Caco-2 cells maintained 
undifferentiated, displaying only few apical microvilli and do not express sucrase 
immunoreactivity (indicator of microvilli). At confluence they form polarized monolayers 
joined by tight junctions and presenting well-developed apical microvilli [88]. Despite their 
colonic origin, Caco-2 cells express the majority of morphological and functional 
characteristics of absorptive intestinal cells (Table 1. 2), inclusive enzymes such as 
disaccharidases and peptidases typically expressed by enterocytes. Adding to that, Caco-2 
cells do not constitute a passive membrane, confirmed by identification of multiple uptake 
and efflux transporters [89]. However, the most important metabolizing enzyme in the human 
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gut, CYP3A4, is low or absent in Caco-2 cells, overestimating the fraction absorbed for 
substrates to 3A4 [90]. 
 Some complications have been reported with respect to this cell line such as the high 
and variable expression of P-gp and low expression of metabolising enzymes. Added to that, 
the pore size of Caco-2 cells is estimated to be approximately 3.7 ± 0.1 Å, tremendously 
underestimating the paracellular transport [91]. The relatively wide variation of the 
correlation profiles between different laboratories and within the same laboratory appears to 
be a disadvantage, resultant of different culture conditions, protocols or genetic drift [81, 
92]. 
 
Table 1. 2. Morphological and functional characteristics of Caco-2 cell line [79, 88, 90, 93]. 
 
MORPHOLOGY 
Grow in monolayer, polarized morphology, microvilli on the 
apical side, tight junctions between the adjacent cells and 
express small intestinal hydrolase enzyme activities (sucrase-
isomaltase, lactase, aminopeptidase N, dipeptidylpeptidase IV). 
INTEGRITY PARAMETERS 
Transepithelial electrical resistance after confluence and 
permeability marker compounds (mannitol). 
MEMBRANE IONIC 
TRANSPORT 
Na+/K+ ATPase, H+/K+ ATPase, Na+/H+ exchange, Na+/K+/Cl- co-
transport, apical Cl- channels. 
MEMBRANE NON-IONIC 
TRANSPORTERS 
Permeability-glycoprotein (P-gp) and multidrug resistant 
associated protein (MRP). 
RECEPTORS 
Vitamin B12, vitamin D3, epidermal growth factor and sugar 
(GLUT1, GLUT3, GLUT5, GLUT2, SGLT1) transports. 
DIGESTIVE ENZYMES 
Typical membranous peptidases and disaccharidases of the 
small intestine. 
 
  
 Besides the correlation that exists between in vivo drug absorption and Caco-2 
permeability [82, 94], the permeability of hydrophilic compounds generally transported by 
paracellular pathway is low in Caco-2 monolayer because of the relatively tighter junctions 
compared with human and animal small intestine, which is explained by their colonic origin 
[95]. Also, the absence of mucus layer will enhance the transport of small molecules due to 
their molecular characteristics [95]. Furthermore, Caco-2 model cannot differ between 
cellular transport or intestinal metabolism, since main barriers opposing drug absorption are 
not completely represented by this model [96]. 
 Despite the widespread use and acceptability of the Caco-2 cell model for permeability 
assessment, other alternatives have been purposed to overcome Caco-2 limitations (Table 1. 
3).  
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Table 1. 3. Alternatives to in vitro drug permeability studies. 
CELL LINE CHARACTERISTICS REFERENCE 
MDCK 
(Madin Darby Canine Kidney) 
- Superior model in terms of passive model compared to 
the Caco-2 model (lower TEER values); 
- Polarized cells with low intrinsic expression of ABC 
transporters; 
- A non-human (dog) and non-intestinal (renal) cell line; 
- Ideal for transfections; 
[97, 98]  
LLC-PK1 
(Pig kidney epithelial cells) 
- Polarized cells with low intrinsic transporter 
expression; 
- Ideal for transfections; 
[3] 
TC7 
(Caco-2 subclone) 
- Higher levels of CYP3A4 e 3A5; 
- Useful to evaluate metabolic effects during transport; 
- Greater homogeneity ensuring more consistent results 
with lower variability 
[99-101] 
2/4/A1 
(Rat fetal intestinal cells) 
- Recommended for passive paracellular transport 
(leakier monolayers with paracellular pore radius of 9.0 
± 0.2 Å, similar to the human small intestine); 
- TEER values reached a plateau of 50 Ωcm2, near of the 
estimated small intestinal TEER values. 
[3, 79, 
102] 
IEC-18 
(Rat intestinal cell line) 
- Provides a size selective barrier for paracellularly 
transported compounds. [3] 
 
 
1.7.4. Co-culture models 
 
 Caco-2 model lacks in some characteristics that influence drug absorption, for instance, 
mucus production. With the objective of mimicking the heterogeneity of populations in 
intestinal epithelium, new Caco-2–based models have been purposed with the introduction of 
new cell lines. 
 In this sense, Caco-2 monocultures evolved to co-cultures of Caco-2 and HT29-MTX cells 
in a similar ratio of the in vivo proportions. HT29-MTX cells are a modified cell line treated 
with an anticancer drug methotrexate (MTX). This cell line came from HT29 cells that exhibit 
variable differentiation depending on the culture medium changes or differentiation inducers. 
For instance, when HT29 cells are treated with MTX at 10-7 M, they form a mixed population 
of absorptive and goblet cells. Increased concentrations (10-6 to 10-5 M) of MTX lead to a 
population exclusively composed by goblet cells secreting gastric mucins. At higher 
concentration, is observed a phenotypic change from the mucus to the absorptive phenotype 
[88]. 
 HT29 cells do not express P-gp and are morphologically distinguished from Caco-2 by 
the presence of sparse and shorter microvilli, whereas the dimensions of both cells are similar 
[77]. Caco-2/HT29-MTX model reveals paracellular permeability closer to human situation but 
the active transport of drugs is underestimated by this model [103]. Interesting works are 
pointed as proof the concept of this model [103-105]. 
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 The promising characteristics of M cells in the induction of specific mucosal immune 
responses have stimulated the in vitro replication of these cells [8]. As result, a new cell 
culture system consisting of Caco-2 cells and human Raji B lymphocytes aim to establish a 
model expressing M-like cells originating from Caco-2 conversion by B lymphocytes. This 
conversion is revealed by the loss of microvilli and consequently by the loss of expression of 
apical enzymes such as alkaline phosphatase [106-108]. 
 
 
 INTRODUCTION 
 
18 
 Table 1. 4. Summary of the pros, cons and costs of the intestinal models drug screening and permeability.  
 
 MODELS 
IN SILICO EX VIVO IN VITRO IN SITU IN VIVO 
 “Rule of five” 
Ussing Chamber 
Everted intestinal sac 
Caco-2, HT29-MTX cells and Raji B 
lymphocytes 
Perfusion of drug solution 
through intestinal segments 
Rats, monkeys, dogs and pigs 
PROS 
- Easy access; 
- High- throughput; 
- Reduce the time-
consuming step of 
synthesis; 
- High level of 
automation. 
- Retains gut architecture; 
- Analysis of different regions of 
intestine; 
- The quantity of sample is 
small and the collected samples 
are analytically clean; 
- Possibility of bidirectional 
transport; 
- Animal or human models. 
- Encompass many characteristics of 
the intestinal epithelium; 
- Represents many absorption 
process; 
- Can be partly automated; 
- Information of cell retention; 
- Benefits in ethical considerations; 
- Performed under standardized and 
controlled conditions. 
- Presence of an intact blood, 
nerve supply and clearance 
capabilities mimic the in vivo 
conditions; 
- Evaluation of the intestinal 
absorption influences the 
hepatic first pass metabolism; 
-Good correlation with the 
pharmacokinetics studies. 
- Integration of the dynamic 
components that affect the drug 
dissolution; 
- Relatively to rats, similar 
absorption profile, low cost and 
easy care handling. 
- Monkeys have evolutionary 
proximity with humans; 
- Pigs have similarity of large 
intestine. 
CONS 
- Insufficient data base 
with reliable data; 
- Low integration of 
physiological 
complexity. 
- Tissue viability; 
- Intrinsic difficult in dissect the 
epithelial tissue; 
- Low- throughput; 
- Requires secondary detection; 
- Large inter-lab variability; 
- Difficulty on isolate the 
contribution of one absorption 
pathway; 
- Tissue availability; 
- The drug must cross the whole 
intestinal wall. 
- Requires secondary detection; 
- Static model; 
- Lack in physiological factors 
(mucus, bile salts); 
- Genetic drift; 
- Low differentiation of low/medium 
absorption; 
- Large inter-lab variability; 
- Labor-intensive; 
- Contamination issues; 
- Influence of all organism is not 
taken into account; 
- Long-differentiation period. 
- The method relies on the 
disappearance of compound 
from the luminal side, but the 
rate of decrease of 
concentration does not always 
represent the rate of 
absorption; 
- Requires a huge number of 
animals and high amounts of 
test compounds; 
- No screening control. 
-  Data extrapolation must be 
done carefully due to species 
differences; 
- Impact of the anatomical and 
physiological differences; 
- Difficulty in separate variables 
involved in the process of drug 
absorption; 
- Ethical concerns; 
- Extensively resource-intensive. 
-  “The only real model for a man 
is man.” 
COSTS 
- High development 
costs. 
- High costs per result analysis. 
- High in terms of tissue facilities and 
time-consumable. 
- High costs. - High costs per result analysis. 
REFERENCES [80, 82, 87, 92] [79, 92, 109] [21, 88, 91, 96, 104, 105, 110-112] [113-115] [83-85, 113] 
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2.1.   Aim and objectives 
 
 Caco-2 cell model is the gold standard of intestinal in vitro models that after 21 days of 
culture become differentiated and polarized cells. Their phenotype morphologically and 
functionally resembles the absorptive enterocytes in many of features, such as, the presence 
of microvilli, expression of tight junctions, enzymes (alkaline phosphatase, sucrose) and 
transporters (P-glycoprotein) [112, 116]. However, the value of this model is usually 
mitigated by tighter tight junctions [91], up-regulation of P-gp [78] and absence of mucus 
[117]. Gradually, new models have been purposed including Caco-2/ HT29-MTX models [104, 
105, 118, 119], Caco-2/Raji B models [21, 120, 121] and Caco-2/HT29-MTX/Raji B models 
[106-108]. Increasingly, epithelial-stromal interactions have been recognized important 
players in the maintenance of intestinal architecture. In specific, subepithelial myofibroblasts 
form a tridimensional network with the underlying cells and play supportive roles promoting 
epithelial regrowth and enhancement of barrier function [50].  
The herein work presents a scenario of interaction between epithelial and stromal 
cells, replicating the mucosal architecture in such a way that the epithelial layer of Caco-2, 
HT29-MTX and M-like cells lie over a 3D network of CCD18-Co intestinal myofibroblasts 
embedded in Matrigel®. The primary aim of this work was to develop a novel intestinal model 
able to predict the drug permeability of any compound, as closest as the in vivo situation. 
Furthermore, this model has potential to dissect the mutual effect of epithelial and stromal 
cells in the maintenance of an intact barrier throughout the production of ECM components.  
To characterize this model, were established 3 main tasks which aimed to characterize 
the fibroblastic and epithelial layer, visualize the tridimensional architecture of the model 
and assess their functional character. Concerning the 21 days of culture and the 3D 
architecture, CCD18-Co cell density was optimized. Regarding the epithelial layer, the 
proportion of Caco-2 and HT29-MTX cells was of 9:1 as this ratio replicates the in vivo 
percentage of goblet cells [122] and was previously optimized by our group [107]. The 
evolution of the barrier model was followed by measuring the transepithelial electric 
resistance (TEER), evaluating the expression of tight junction proteins between the different 
epithelial cells, the production of mucus by HT29-MTX cells and the presence of M-like cells. 
At last, the functional character of the 3D model was assessed by determining the absorption 
profile of a protein drug, insulin. 
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3.1. Materials 
 
Dulbecco’s Modified Eagle’s Medium (DMEM), Non-essential aminoacids (NEAA), 0.05% 
Tripsin-EDTA, 0.4% Trypan Blue, Hanks Balanced Salt Solution (HBSS), Phosphate Buffer 
Solution (PBS), DMEM without phenol red were purchased from Gibco®, while Fetal Bovine 
Serum (FBS) and Penicillin/Streptomycin were purchased from BioWest. 
Resazurin, Human Insulin, Alcian Blue 8GX, DAPI, FluoroshieldTM mounting medium, 
Poly-D-Lysine (PDL), 3-aminopropyltriethoxysilane (APES), hexamethyldisilazane (HMDS), 
Phosphate Substrate (p-NPP) and Propidium Iodide (PI) were purchased from Sigma. 6-well 
Transwell® permeable support (PET membrane and 3μm pore size) and Matrigel® basement 
membrane matrix were purchased from BD Biosciences. ClearRite 3, Neg-50TM frozen section 
medium, paraffin and alcoholic eosin were purchased from Thermo Scientific. Sodium-
cacodylate was purchased from Fluka®. Calcein-AM was purchased from Invitrogen. DC Protein 
Assay Kit was purchased from Bio-Rad. Gill’s Haematoxylin II was purchased from Surgipath. 
Quick-D mounting medium was purchased from Klinipath. Epon resin and propylene oxide 
were purchased from Electron Microscopy Sciences. 
Anti-human vimentin antibody was purchased from Santa Cruz Biotecnology. Donkey 
anti-mouse AlexaFluor 488®, goat anti-mouse AlexaFluor 594®, goat anti-rabbit AlexaFluor 
594®, goat anti-rabbit AlexaFluor 488® secondary antibodies and Quant-iT PicoGreen dsDNA 
kit were purchased from Molecular Probes®. Rabbit anti-fibronectin polyclonal antibody was 
purchased from Sigma. Mouse anti-claudin-5 monoclonal antibody was purchased from Life 
Technologies. Rabbit anti-human E-cadherin (24A10) was purchased from Cell Signaling. 
 
3.2. Establishment of in vitro models 
 
3.2.1. Cell lines and cell culture conditions 
 
Caco-2 cell line and HT29-MTX was from American Type Culture Collection (ATCC, USA). 
Raji B cell line was kindly provided by Dr. Alexandre Carmo (Cellular and Molecular Biology 
Institute – IBMC, Porto, Portugal). CCD18-Co was kindly afforded by Dr. Sérgia Velho (Institute 
of Molecular Pathology and Immunology of the University of Porto, IPATIMUP, Porto, 
Portugal). 
CCD18-Co (passage 8-13), Caco-2 (passage 22-40) and HT29-MTX (passage 25-40) cells 
grown separately in tissue culture flasks (Orange Scientific) in DMEM basal medium  
supplemented with 10% (v/v) of inactivated FBS, 1% (v/v) of NEAA and 1% of 
antibiotic/antimitotic mixture (final concentration of 100 U/mL Penicillin and 100 U/mL of 
Streptomycin). Cells were routinely observed and, when confluence reached to 80%, 
subcultured with 0.05% Trypsin-EDTA and seeded at a density of 6×105 cells per 75 cm2 flask. 
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The medium was replaced every other day. Raji B cells (passage 30-42) were maintained as 
aforementioned and seeded at a density of 1×106 cells per 75 cm2 flask. 
Cells were maintained in an incubator (CellCulture® CO2 Incubator, ESCO) at 37°C and 
5% CO2 in water saturated atmosphere. All the cell culture related procedures were done in a 
Labculture® class II, type A2 biological safety cabinet, ESCO. 
 
3.2.2. Cell thawing 
 
All cells were frozen at liquid nitrogen. It is essential to thaw the cell correctly in order 
to maintain the viability of the culture and allow them to recover quickly. Furthermore, some 
cryoprotectants, such as DMSO, are toxic above 4°C so cultures should be thawed quickly and 
diluted in culture medium to minimize the toxic effects. Despite this, DMSO protects the cells 
from rupture by the formation of ice crystals. 
The basic principle of a successful resuscitation is a quick thaw, by incubation in a 37°C 
water bath for 3-4 minutes. All the content in the cryovial (CryoVial®, Falcon) was transferred 
to a new container with pre-warmed culture medium and centrifuged at 18 G for 5 minutes at 
4°C to remove at DMSO. The supernatant was discarded and the pellet was resuspended in 
pre-warmed complete DMEM. The content was transferred to a tissue culture flask (Orange 
Scientific) and cell viability was evaluated after 24 hours. 
 
3.2.3. Optimization of CCD18-Co cells density 
 
To determine the optimal density of CCD18-Co intestinal myofibroblasts, different 
cellular densities of 1x104 cells/cm2, 5x104 cells/cm2, 10x104 cells/cm2 and 20x104 cells/cm2 
were evaluated regarding their viability, metabolic activity, proliferation and morphological 
features.  
 
3.2.3.1. Cell viability 
 
At different time points, CCD18-Co cells were washed twice with pre-warmed DMEM 
without phenol red to remove/dilute estereases and incubated with Calcein-AM diluted in 
DMEM without phenol red (1:250) for 40 minutes at 37⁰C. After washed twice with DMEM 
without phenol red, samples were incubated with PI diluted in DMEM without phenol red 
(1:250) for 10 minutes at 37⁰C. Samples were finally washed twice with DMEM without phenol 
red and immediately examined under an Axiovert 200M inverted fluorescent microscope from 
Zeiss. Live cells are distinguished by the presence of ubiquitous intracellular esterase activity 
that is able to digest non-fluorescent calcein-AM into fluorescent calcein emitting green 
fluorescence [111]. In contrast, dead cells with damaged membranes allow the entrance of 
propidium iodide (PI) that emits a bright red fluorescence upon binding to the acid nucleic. 
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3.2.3.2. Cell metabolic activity 
 
Metabolic assays were conducted using the resazurin fluorescent assay. Representative 
of 3D condition, CCD18-Co cells were embedded Matrigel® matrix, while other set was 
prepared by seeding CCD18-Co, case of study representative of 2D standard conditions. 
Resazurin pre-warmed to 37°C was added to the plates in a 10% concentration of the 
initial volume in the plate and cells in culture for 7 days were incubated at 37°C. After 
incubation, a sample was collected and immediately quantified by measuring the relative 
fluorescence units (RFU) using a microplate reader SynergyTM Mx HM550 (BioTek® Instruments, 
USA) set at 530/590 nm (excitation/emission wavelength, respectively). The results were 
normalized by subtracting the negative control (without cells). The assay was repeated for 14 
and 21-days cultures.  
In this assay, the cellular metabolic activity is detected through the reduction of a blue 
non-fluorescent resazurin reagent into a highly fluorescent resorufin by the dehydrogenase 
enzyme in metabolically active cells. This conversion is proportional to the number of viable 
cells in the sample. 
 
3.2.3.3. Total dsDNA quantification 
 
After recover the cells by trypsinization, the cell suspension was centrifuged at 18 G for 
5 minutes, washed with PBS, centrifuged again and the pellet was stored at -20⁰C until 
quantification. Cells were lysed with 1% (v/v) Triton X-100 for 1 hour under agitation at 4⁰C. 
Since 1% (v/v) Triton X-100 interferes with the measurement, samples were diluted to a final 
concentration of 0.4% (v/v) Triton X-100 with PBS and the double-stranded DNA (dsDNA) was 
quantified using the Quant-iT PicoGreen dsDNA kit, according to manufacturer’s instructions. 
Briefly, 10 μL of each sample was transferred to a black 96-well plate with clear bottom 
(Falcon) and diluted with 90 μL of TE (1x) buffer (200mM Tris-HCl, 20 mM EDTA, pH 7.5). To 
each well, was added 100 μL of PicoGreen dsDNA reagent and incubated for 5 minutes at RT, 
protected from light. Samples were quantified using a microplate reader SynergyTM Mx HM550 
(BioTek® Instruments, USA) set at 480/530 nm (excitation/emission wavelength, 
respectively). The dsDNA concentration (ng/mL) was determined using a standard curve of 
lambda DNA in a range of 0.0250-2.50 ng/mL. 
 
3.2.3.4. Cell morphology 
 
 CCD18-Co cells morphology was assessed by labeling the intermediate filaments of 
fibroblasts with vimentin antibody.  
 Briefly, CCD18-Co cells, previously seeded on coverslips coated with PDL, were rinsed 
twice with pre-warmed PBS+ (1.37 M NaCl, 26.8 mM KCl, 14.7 mM KH2PO4, 78.1 mM Na2HPO4, 
1mM Ca2Cl, 1mM Mg2Cl, pH 7.4), regular PBS supplemented with Ca
2+ and Mg2+ ions to 
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maintain the integrity of cellular junctions. Cells were fixed with 2% (w/v) paraformaldehyde 
(Merck, VWR) in PBS+ for 15 minutes at room temperature (RT), following  permeabilization 
with freshly prepared solution of 0.2% (v/v) Triton X-100 (Sigma®, Sigma Aldrich) in PBS+ for 7 
minutes at RT. In order to block non-specific binding, samples were incubated with a freshly 
prepared solution of PBST (PBS+ containing 0.05% (v/v) Tween-20 (AppliChem, VWR)) 
containing 10% (v/v) FBS for 30 minutes in a humidified chamber. Then, without wash, 
blocking solution was removed and samples were separately incubated during 2 hours at RT 
with a mouse anti-human vimentin primary antibody diluted (1:100) and a donkey anti-mouse 
AlexaFluor488® secondary antibody (1:1000) during 1 hour at RT, both diluted in PBST 
containing 5% (v/v) FBS. Cell nucleus was counterstained with DAPI diluted 1:1000 in PBS 
during 5 minutes. With exception of the blocking step, were performed 5 minutes washes 
with PBS+ between fixation, permeabilization and incubation steps. The coverslip  was placed 
face down to the glass slide with a drop of mounting medium of FluoroshieldTM and visualized 
using an Axiovert 200M inverted fluorescent microscope from Zeiss. 
 The acquired images were taken using Axiovision 4.8.2 SP3 from Zeiss and treated using 
ImageJ program. The staining was repeated for 14 and 21 days old cultured cells to 
understand the effect of the initial cell density on fibroblasts morphology. 
 
3.2.4. Production of ECM components 
 
CCD18-Co cells entrapped in Matrigel were evaluated regarding expression of ECM 
components, namely fibronectin. Moreover, the 3D arrangement of CCD18-Co cells entrapped 
in the Matrigel matrix was also assessed. The procedure was performed as previously reported 
for paraffin sections with exception of the incubation step. Briefly, cells were incubated 
during 2h at RT with both mouse anti-human vimentin primary antibody (1:100) and rabbit 
anti-human fibronectin primary antibody (1:400). After 5 minutes washes, a goat anti-mouse 
AlexaFluor594 secondary antibody (1:1000) and a goat anti-rabbit AlexaFluor488 secondary 
antibody (1:1000) were incubated during 1 hour at RT and protected from light. Cell nucleus 
was counterstained with DAPI diluted 1:1000 in PBS during 5 minutes.  
 
Paraffin-embedded sections of the 3D model (CCD18-Co+Matrigel/Caco-2/HT29-
MTX/Raji B) were stained to evaluate the supportive role of fibroblasts embedded in self- 
produced extracellular matrix.  First, sections were deparaffinise with ClearRite for 10 
minutes and hydrated through graded series of ethanol finishing with PBS (1x), during 5 
minutes in each solution. Sections were fixed with 4% (w/v) paraformaldehyde (Merck, VWR) 
in PBS+ for 20 minutes at RT, following a permeabilization with freshly prepared solution of 
0.2% (v/v) Triton X-100 (Sigma®, Sigma Aldrich) in PBS+ for 9 minutes at RT. The blocking was 
performed with 1% BSA in PBS+ during 30 minutes at RT. Then, without wash, blocking solution 
was removed and sections were incubated during 2 h at RT with a rabbit anti-human 
fibronectin primary antibody (1:400) and a goat anti-rabbit AlexaFluor488 secondary antibody 
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(1:1000) during 1 hour at RT, both diluted in 1% BSA in PBS+. Cell nucleus was counterstained 
with DAPI diluted 1:1000 in PBS during 5 minutes. With exception of the blocking step, were 
performed 5 minutes washes with PBS+ between fixation, permeabilization and incubation 
periods.  
Samples were mounted with FluoroshieldTM, visualized using an Axiovert 200M inverted 
fluorescent microscope from Zeiss and treated using ImageJ program.  
 
3.2.5. Monolayer in vitro models 
 
As manner of proof, single and co-culture monolayers were performed comprising Caco-
2, HT29-MTX, CCD18-Co and Raji B cells. By single monolayers are intended Caco-2 and 
CCD18-Co monolayer’s while co-culture monolayers involve CCD18-Co/Caco-2 cells, Caco-
2/HT29-MTX cells, Caco-2/Raji B cells and Caco-2/HT29-MTX/Raji B cells.  
Stromal - epithelial co-culture of CCD18-Co/Caco-2 cells (Fig. 3. 1 A) was prepared by 
seeding CCD18-Co at a density of 1×104 cells/cm2 onto 3 μm TranswellTM inserts. In the 
following day, Caco-2 cells were seeded onto CCD18-Co cells at a densitenty of 1×105 
cells/cm2, as described before [106, 107].   
Epithelial co-culture of Caco-2/HT29-MTX cells (Fig. 3. 1 B) was prepared by seeding 
Caco-2 and HT29-MTX cells to a final density of 1×105 cells/cm2 (90:10 proportion), previously 
optimized [107]. These cultures were maintained for further 21 days. 
The epithelial – lymphocyte co-culture of Caco-2/Raji B cells (Fig. 3. 1 C) was prepared 
by seeding Caco-2 at a final density of 1×105 cells/cm2 in the apical side of the TranswellTM 
insert, while 1×106 cells/6-well Raji B lymphocytes were added to the basolateral side after 
14 days in culture. Until the end of 21 days, medium was changed every other day only at the 
apical compartment.  
The triple model of Caco-2/HT29-MTX/Raji B cells (Fig. 3. 1 D) was performed as 
described before [106, 107] based on the Caco-2/HT29-MTX co-culture with the addition of 
Raji B cells in the basolateral side.   
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Figure 3. 1. Schematic configuration of monolayer in vitro models. (A) Stromal – epithelial monolayer 
comprising CCD18-Co and Caco-2 cells. (B) Epithelial monolayer comprising Caco-2 and HT29-MTX cells. (C) 
Epithelial - lymphocyte monolayer representative of the formation of M-like cells. (D) Triple model comprising 
Caco-2, HT29-MTX and M-like cells. 
 
3.2.6. Tridimensional in vitro models 
 
To explore the impact of CCD18-Co cells’ assembly in the barrier formation were tested 
distinct configurations. The first configuration consists on Caco-2 cells beneath CCD18-Co 
cells embedded in Matrigel (CCD18-Co cells in 3D assembly) (Fig. 3. 2 A) and the second 
configuration consists on CCD18-Co and Caco-2 cells separated by a gel layer of Matrigel 
between both cell types (CCD18-Co cells in 2D assembly) (Fig. 3. 2 B).  
For the first configuration, 1×104 cells/cm2 of CCD18-Co cells were entrapped in a thick 
layer (400μL) of Matrigel (1:3) diluted in ice-cold DMEM without FBS. The cell suspension was 
spread evenly by the Transwell® insert from the centre to the periphery, avoiding bubbles. 
The Transwell® insert was transferred to the incubator at 37°C and allowed to polymerize for 
30 minutes. After that, DMEM was gently added to both sides of the Transwell® insert. After 
24h, 1×105 cells/cm2 of Caco-2 cells were added over the layer of CCD18-Co embedded in 
Matrigel®.  
For the second configuration, CCD18-Co cells were seeded to a final density of 1×104 
cells/cm2. In the following day, DMEM as removed and a thin layer (200μL) of Matrigel® (1:3) 
was added onto the CCD18-Co monolayer. After 30 minutes of polymerization, Caco-2 cells 
were carefully added over the Matrigel® layer. The cell density of CCD18-Co cells was based 
on preliminary studies and both culture models were maintained for further 21 days.  
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To advance to further studies was adopted the first configuration based on the 
preliminary studies obtained. Moreover, this arrangement closely mimics the intestinal 
mucosa. The final model, which adds HT29-MTX and M-like cells converted by Raji B cells, is 
represented in Fig. 3. 3. 
 
 
Figure 3. 3. Schematic configuration of the 3D quadruple model. 
 
 
 
 
 
 
Figure 3. 2. Schematic configuration of the double 3D in vitro models. (A) CCD18-Co cells embedded in a 
Matrigel® matrix, representing a 3D assembly. (B) CCD18-Co cells seeded on the bottom of the Transwell,  
representing a 2D assembly. 
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3.2.7. Transepithelial electrical resistance (TEER) 
 
To monitor the membrane integrity, the transepithelial electrical resistance (TEER) of 
each model was measured using a voltohmmeter Millicell® ERS-2 (Millipore, USA) every time 
medium was replaced. The values were normalized by subtracting the resistance value of the 
empty Transwell® insert and expressed in ohm per area of the insert (Ω.cm2) through the 
following equation.  
 
3.2.8. Cell proliferation  
  
The effect of the Matrigel® on cell proliferation of stromal and epithelial cells was 
explored by comparing the behaviour of CCD18-Co cells at a density of 1x104 cells/cm2 and 
Caco-2 at a density of 1x105 cells/cm2 in plastic and Matrigel. CCD18-Co cells were also 
seeded on plastic in direct contact with Caco-2 cells.  
After 7 days, cells were washed twice with PBS (1.37 M NaCl, 26.8 mM KCl, 14.7 mM 
KH2PO4, 78.1 mM Na2HPO4, pH 7.4) and detached from substrates with 0.05% trypsin-EDTA 
during 10 minutes at 37⁰C. Trypsin-EDTA mixture was inactivated with DMEM and the plates 
were observed to the microscope to assure that all cells were detached; otherwise 
trypsinization was repeated. Each sample was mixed with 0.4% (v/v) Trypan Blue to 
determine the cell number using a haemocytometer (Marienfeld-Superior, Germany). 
 
3.2.9. Paraffin sections and histological staining 
 
Membranes were embedded in paraffin to observe the layers that constitute the 3D 
model. Briefly, membranes were washed twice with PBS before fixed with 4% 
paraformaldehyde for 1 hour and post-fixed with 1% glutaraldehyde for 15 minutes to avoid 
depolymerization of Matrigel.  Membranes were washed twice with PBS and cut with a scalpel 
to be processed automatically in a Spin Tissue Processor STP120 (Thermo Scientific, Germany) 
that consisted in graded dehydrations in ethanol for 10 minutes each, followed by a 
diaphanization using ClearRite 3 for 10 minutes twice. Membranes processing was finished by 
placing membranes in liquid paraffin for 2 hours. Membranes were orientated according the 
plane of cut and sectioned with a thickness between 5-10 μm using a Leica RM2255 microtome 
(Leica Biosystems, Germany). The glass slides with the sections were allowed to dry overnight 
at 37°C before haematoxylin and eosin staining. 
Briefly, for the haematoxylin and eosin staining, sections were dewaxed in ClearRite 3 
for 10 minutes. After that, sections were hydrated through graded alcohols to water for 2 
minutes each, following the staining with Gill’s haematoxylin II for 5 minutes. Sections were 
abundantly washed in tap water for 2 minutes, following dehydration through graded alcohols 
for 2 minutes each. Sections were stained with alcoholic eosin for 3 minutes and sections 
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were dipped in absolute alcohol 3 quick times. At last, sections were dipped in xylene three 
times and mount in Quick-D permanent mounting medium. 
 
3.2.10. Expression of junctions proteins 
 
Immunofluorescence staining was used to determine the expression of the TJ proteins 
claudin-5 and occludin and adherent junction protein E-cadherin.  
Regarding claudin-5 labeling, cells were washed twice with pre-warmed PBST for 1 
minute each. After that, cells were fixed with 2% (w/v) PFA for 15 minutes at RT following 
the permeabilization step with 0.2% of Triton during 5 minutes. After washes, the non-
specific binding was blocked with PBST containing 10% FBS for 30 minutes. Then, without 
wash, the mouse anti-claudin-5 conjugated with AlexaFluor 488 antibody was incubated 
during 1 hour in a 1:100 dilution in PBS. Samples were washed with PBS+ and incubated with 
DAPI (1:1000) for 5 minutes to label the cell nuclei. 
Regarding the occludin labeling, cells were washed with cold PBS+ and fixed for 10 
minutes on ice with methanol. After this, cells were washed 3 times for 5 minutes with PBS+ 
and non-specific binding was blocked incubating with 5% (v/v) BSA at RT. Then without wash, 
mouse anti-occludin conjugated AlexaFluor 594 antibody was incubated for 1 hour at RT and 
protected from light, in a dilution of 1:100 in PBS. Samples were washed with PBS+ and 
incubated with DAPI (1:1000) for 5 minutes to label the cell nuclei. 
Concerning the E-cadherin labeling, samples were washed with PBS+ that allows the 
maintenance of junctions, following fixation with 4% (w/v) PFA for 20 minutes at RT. Samples 
were incubated with 50 mM NH4Cl (Sigma
®) for 10 minutes that blocks aldehyde groups 
allowing a better antibody-antigen bonding. After permeabilization with 0.2% Triton for 5 
minutes, the non-specific binding was blocked with 5% BSA for 30 minutes. The blocking 
solution was removed and samples were incubated with the rabbit anti-human E-cadherin 
primary antibody diluted to 1:100 in 5% BSA for 2 hours. It follows the incubation with the 
goat anti-rabbit AlexaFluor488 secondary antibody diluted to 1:500 in 5% BSA. The staining 
was finalized with nuclei labeling with DAPI (1:1000). Samples were mounted with 
FluoroshieldTM and visualized using an Axiovert 200M inverted fluorescent microscope from 
Zeiss.  
 
3.2.11. Alkaline phosphatase assay 
 
Alkaline phosphatase activity was measured in situ live cells according to Ferruza et al. 
using p-Nitrophenyl (p-NPP) as substrate [123]. Alkaline environment catalyses the hydrolysis 
of p-NPP to a inorganic phosphate and p-Nitrophenol (p-NP), a yellow soluble end-product. 
The intensity of the colored product is proportional to the enzyme activity measured at pH 
9.3 at 405 nm. 
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Briefly, after removing the cell medium and gently wash the monolayer with PBS+ (1mM 
CaCl2 and 1mM MgCl2), reaction buffer consisting of one volume of collection buffer (10 mM 
Tris-HCl, 150 mM NaCl pH 8.0) and three volumes of pNPP solution (100 mM Tris-HCl, 100 mM 
NaCl, 5 mM MgCl2, pH 9.5) was added to the well, kept at 37°C in water bath. At different 
time points, 100 μL was collected and transferred to a 96-well plate containing 50 μL of 0.5M 
of NaOH to stop the reaction. The standard curve was prepared with 50 μL of eacg p-NP 
concentration ranging from 0 to 600 μM, added to 150 μL of p-NPP solution and 50 μL of 0.5M 
NaOH. Absorvance was determined using a SynergyTM Mx HM550 microplate reader (BioTeK® 
Instruments, USA) and normalized by blank subtraction. Concentration was determined with 
reference to the standard curve and corrected for the reaction volume before plotting was 
function of the time. The angular coefficient of the linear slop of this plot represents the 
enzymatic activity expressed as mU= nmol of p-NP/min at 37°C and normalized to mg of 
cellular protein measured Bio-Rad DC Protein Assay, a Lowry-based assay [124]. 
 
3.2.11.1. Protein quantification 
 
After the alkaline phosphatase assay, samples were lysed for further protein 
quantification using Bio-Rad DC Protein Assay, which is equivalent to the well documented 
Lowry assay. This assay is based in two steps that lead to the color development. First, the 
reaction between the protein and the copper in an alkaline medium (Reagent A) and 
subsequent reduction of Folin Reagent (Reagent B) by the copper treated protein [124]. 
The assay was performed according to the manufactures instructions. Briefly, cells 
were incubated with the lysis buffer (250mM Tris and 0.1% Triton) for 20 minutes at RT. The 
cell suspension was collected and was added 1 volume of dilution buffer (250mM Tris) to 
reduce the amount of detergent. Samples were vortex and frozen until further quantification. 
For quantification purposes, samples were centrifuged at 18 G for 5 minutes to pellet the 
insoluble material and 5μL of each standard and samples was transferred to a 96-well plate, 
at which was added 25 μL of Reagent A’ (20 μL of Reagent S to each mL of Reagent A) and 200 
μL of Reagent B. The plate was mixed for 5 seconds and after 15 minutes, absorbance was 
read at 750 nm. Concentration was determined with reference to a standard curve of BSA 
between 1.5 mg/mL and 0.125 mg/mL. 
 
3.2.12. Scanning electron microscopy  
 
After  21  days  in  culture,  Transwell membranes  were washed twice in PBS+, 
following primary fixation with  3%  (v/v)  Glutaraldehyde (AGAR Scientific, AGAR Scientific)  
for  45  minutes.  After  rinsing  with  0.1M  sodium-cacodylate  buffer,  membranes  were 
dehydrated  through  a  graded  series  of  ethanol,  subsequently  dried  with  75% (v/v) 
hexamethyldisilazane  (HMDS) in ethanol for  10  minutes.  Without remove HMDS, Transwell 
inserts were allowed to air-dry for 30 minutes. The membrane of the Transwell inserts was 
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removed from the base of the insert using a scalpel and mounted on double-side stick tape 
SEM stubs. The samples were stored in a desiccator until coated.  Sputter coat was with gold-
palladium at 15 mA for 120 seconds under argon atmosphere and images were acquired using 
a scanning electron microscope (Quanta 400FEG ESEM/EDAX Genesis X4M). 
 
3.2.13. Transmission electron microscopy  
 
After 21 days in culture, Transwell membranes were washed twice in PBS+, following 
primary fixation with 2.5% (v/v) Glutaraldehyde (AGAR Scientific, AGAR Scientific) in 0.1M 
sodium cacodylate during 3 days at 4°C. After rinsing with 0.1M  sodium-cacodylate  buffer, 
membranes were post-fixed in  2% (v/v) osmium in 0.1M sodium cacodylate buffer overnight. 
Membranes were washed with 0.1M  sodium-cacodylate  buffer, following dehydration through 
a graded  series  of  ethanol and propylene oxide for 10 minutes each. The membrane was 
infiltrated in embedding resin as follows: propylene oxide and epon (2:1 proportion), 1:1, 1:2 
and 0:1 during 1 hour each. After that, resin was allowed to harden during 48 hours in an 
incubator set at 65°C. The block was sectioned with 60 nm of thickness using a Leica Reichert 
SuperNova ultramicrotome (Leica Microsystems, Germany) and samples are collected to an 
aluminum disk. The disks were contrasted using uranyl acetate and lead citrate during 5 
minutes in each solution. Images were acquired using a transmission electron microscope Jeol 
JEM 1400. 
 
3.2.14. Drug transport assay 
 
In order to determine the permeability of model drugs through the developed cell-
based models, permeability studies were performed correlating the obtained values with the 
in vivo data. To start, culture medium was removed from both chambers and the cells 
membranes were washed with pre-warmed HBSS, further replaced by new HBSS and allowed 
to equilibrate for 15 minutes at 37°C. After this period it is expected that cell cultures reach 
a constant TEER value. Permeability studies were run at 37°C during 4 hours with 1.5 mL of 
100 μg/mL insulin prepared in HBSS in the apical side and 2.5 mL of HBSS in the basolateral 
side. 
Cell monolayer integrity during permeability studies was controlled by TEER 
measurement before collect the samples in different time points. The samples were further 
quantified by reverse HPLC-UV on a Merck-Hitachi LaChrom HPLC instrument (Merck). The 
HPLC system was equipped with a XTerra RP-18 column, 5 μm particle size, 4.6 mm internal 
diameter × 250 mm length (Waters) and a LiChrospher 100 TP-18, 5 μm particle size guard 
column (Merck) [125]. All experiments were run in triplicate at room temperature and the 
total area of the peak was used to quantify insulin. The results were expressed in percentage 
of release and apparent permeability (Papp).  Papp was calculated using the following equation: 
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, where C0 is the initial concentration in the apical compartment (μg/mL), A is the surface 
area of the insert (cm2), ∆t is the time in which the experiment occurred (seconds) and ∆Q is 
the amount of compound detected in the basolateral side (μg) [107]. 
 
Complementary studies to integrity were performed at the end of permeability studies 
to evaluate the final integrity state of the models. For this, apical-basolateral flux was 
assessed using 4 kDa Fluorescein Isothiocyanate – Dextran molecule (FITC-Dextran). After 
transport experiments with insulin, it was discarded and Transwell® inserts were washed 
twice with HBSS. After washes, 1.5 mL of 200 μg/mL of FITC-Dextran was added to the apical 
compartment, equilibrated with 2.5 mL of HBSS in the basolateral side. The plate was 
incubated at 37°C, 5% CO2 for 1 hour. After 1 hour, a sample was collected from the 
basolateral side and transferred to a black plate 96-well plate (Falcon). FITC-Dextran 
quantification was determined by fluorescence using a SynergyTM Mx HM550 microplate reader 
(BioTeK® Instruments, USA) set at 485/530 nm (excitation/emission wavelength, respectively). 
Microplate readings were obtained through Gen5 Data Analysis software (BioTek®  
Instruments). Fluorescence values were normalized subtracting the blank and concentration 
was calculated with reference to the standard curve. The amount of transported 4 kDa FITC-
Dextran was expressed by percentage of rejection.  
 
             
                
         
      
 
3.2.15. Statistical analysis 
All the results are presented as the mean±SD. Statistical analysis was performed using 
Graphpad Prism® software (Prism 6 for Windows, CA, USA).  
One way ANOVA, together with Tukey’s post hoc test, was used to compare different 
groups of data. P<0.05 was considered statistically significant. 
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The growing interest in predicting the properties of incoming drugs in the market has 
increasingly valuing the in vitro tools as they may encompasses many characteristics of the 
tissue in question and also benefit from standardized conditions and lack of ethical 
considerations. Nonetheless, the existing in vitro models are restricted to cell monolayers 
that do not replicate the entire architecture and mechanisms occurring in a living tissue 
[126]. Essential cellular functions are missed by ‘petri-dish’-based cell cultures, limiting the 
potential to predict the cellular responses of real organisms. Tridimensional cultures are 
believed to incite a strong impact on drug screening, bridging the gap between cells cultures 
and animal models, with the potential to additionally decrease the use of animals in research 
[127].  
The present study extends a traditional standard intestinal model to the deeper layers 
of small intestine, in particular the intestinal mucosa that includes a broad variety of stromal 
cells. The intimate crosstalk between epithelial and stromal cells was explored using a novel 
in vitro cell based model as a mean of mimic the intestinal mucosa’s architecture and 
functioning and predicts the permeability of a model drug.  
 
4.1.   Analysis of CCD18-Co cells behaviour in 2D and 3D 
 
There is a striking similarity between the morphology and behaviour of cells in vivo and 
in 3D culture conditions [127]. The cell behaviour in 2D and 3D matrices has revealed 
considerable differences in cell morphology [128], migration [129], adhesion [130] and 
signalling [131], comparing to in vivo conditions. Together, these findings empower the 
importance of matrix dimensionality, i.e. 2D vs. 3D. 
The evaluation of cell behaviour in 3D microenvironments is a multifactorial task that 
takes into account matrix extrinsic factors (soluble and direct cell-cell contact signaling) and 
matrix related factors (matrix composition, mechanical properties, mesh size and degradation 
rate) [132]. A recent study highlights the relevance of optimizing initial cell densities when 
establishing 3D cultures [133]. 
To determine the optimal cell number of CCD18-Co cells intestinal myofibroblasts 
several assays were performed, namely viability, metabolic activity and cell morphology over 
21 days of culture, period necessary to fully differentiate Caco-2 cells [93]. In this sense, a 
range of densities of CCD18-Co cells (between 1×104 cells/cm2 (D1) and 20×104 cells/cm2 (D4)) 
was seeded on 24-well plates to assess the most suitable density to be used in further 
experiments.  
4.1.1.  Effect of cell number on viability of CCD18-Co cells in 2D 
 
Cell viability was evaluated at days 7, 14 and 21 by the Live/Dead assay. As observed in 
Fig. 4. 1, after 7 days, the cells remained highly viable for all the range of densities, with 
very few dead cells between them. Despite the high viability at day 14, an alteration of cell 
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shape at density D3 (10×104 cells/cm2) and D4 (20×104 cells/cm2), can already be observed 
since calcein is ubiquitously distributed by the cells. Cells seem to acquire a starry-like shape 
most likely as a result of space constraints at higher cell densities. It is known that high 
density cell culture promotes cell-to-cell contact that can stimulate cell cycle arrest causing 
cells to stop dividing [134], a phenomenon commonly known as contact inhibition [135]. 
The starry-like shape is more accentuated at day 21, indicating that D3 and D4 do not 
seem appropriate cell densities using 2D standard culture conditions. Notwithstanding, 
further morphological assays were carried out to sustain this result. 
 
 
Figure 4. 1. Live/Dead viability assay performed in 2D cultures of CCD18-Co cells. The results showed that at day 
7 (A-D) most of the cells are viable labeled with Calcein-AM (green) presenting an elongated shape. After 14 days (E-
H), cells at higher densities (D3 and D4) start to acquire a starry-like shape with few dead cells labeled with PI (red). 
This tendency aggravates at day 21 (I-L) for lower densities (D2). Scale indicates 100 μm and white arrows indicate 
dead cells. 
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4.1.2.  Effect of cell number on metabolic activity of CCD18-Co cells 
 
The metabolic activity of CCD18-Co cells was evaluated in 3D conditions after 
entrapment in a matrigel matrix and in standard 2D conditions using the rezasurin assay. The 
differences in cell behaviour were evaluated during 21 days. Despite the different culture 
conditions, the time of incubation for both 2D and 3D cultures was 3 hours. 
In 2D standard conditions (Fig. 4. 2 A), the metabolic activity presented a stairway 
profile between D1 and D3 for 7 days. At day 14, an increase in metabolic activity was 
observed for all the cell densities tested, although a growing approximation of the fluorescent 
values between D2, D3 and D4 was noticed. At day 21, the metabolic activity decreased for 
all the densities, probably result of contact inhibition [135]. Concerning the 3D cultures (Fig. 
4. 2 B), the metabolic activity also presented a stairway profile for the first 7 days, 
proportional to the cell densities. At day 14, the increase of metabolic activity at D4 was not 
significant and after 21 days, 3D cultures seemed to acquire a stagnant profile.  
Overall, in the first days of culture, the metabolic activity of 3D cultures was lower 
when compared with 2D cultures. Under 3D conditions, cells have a limited proliferation as 
the matrigel matrix constitutes an obstacle to the proliferation and cells are subject to 
hypoxia. But in fact, after 21 days, the metabolic activity of 3D cultures was higher when 
compared with 2D cultures. This probably indicates that to cells maintain metabolically viable 
they had used their proteolysis machinery and migrated through the matrix [136]. For this 
reason, the choice of matrigel dilution and thickness are important parameters that will 
condition the cell behaviour as the pore size of the matrigel matrix varies with the protein 
concentration. At 50% gel concentration, the average pore size is approximately 2 μm, which 
is much smaller than cellular dimensions [136]. Even though balanced matrix degradation 
allows cell survival throughout matrix remodeling, further studies are necessary to evaluate 
the matrix degradation and production of metalloproteinases (MMPs).  
 
A B 
  
Figure 4. 2. Metabolic activity of CCD18-Co cultured in 2D and 3D along 21 days at different densities. The 
metabolic activity of 3D cultures was higher compared with 2D cultures after 21 days. Results are the average of 
replicates and bars represent the standard deviation (n=3). The statistical differences (p<0.05) are denoted by (*).  
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4.1.3. DNA quantification 
 
As mean to reinforce the results obtained for the metabolic activity in 2D and 3D 
cultures, it was determined the DNA content after 21 days of culture (Fig. 4. 3). At day 1, it 
was observed that the DNA content was proportional to the range of cell densities tested. 
After 21 days, the DNA content in 2D cultures was significantly reduced at D2, D3 and D4 but 
not at D1. This means that at D1, cells did not enter in a process of contact inhibition. 
Therefore, cell densities higher than 1×105 cells/cm2 (D2) are not recommended for cultures 
maintained for 21 days in 2D standard conditions. Cells start to lack of space, detaching and 
being removed as the medium is replaced every other day.  
The decrease in the DNA content observed in 3D is a result of the reduced proliferation 
of cells when are entrapped in a matrix. Notwithstanding, the DNA content was proportional 
to the cell density.  
 
 
Figure 4. 3. Total dsDNA quantification of CCD18-Co cultured for 21 days in 2D standard conditions at 
different densities. After 21 days, the decrease in DNA content in both 2D and 3D cultures was result of contact 
inhibition and matrix constraints, respectively. Results are the average of replicates and bars represent the 
standard deviation (n=3). The statistical differences (p<0.05) are denoted by (*) regarding the control at day 1.  
In summary, when entrapped in a matrigel matrix, CCD18-Co cells revealed a non-
proliferative character, result of the matrix constraints. 
 
4.1.4. Effect of cell number in CCD18-Co cells morphology 
 
There are, at least, three major classes of microenvironmental factors that affect the 
cellular behaviour, i.e., the biochemical composition, the physical parameters of the matrix, 
particularly the pliability, and the spatial cues [137]. 2D surfaces do not represent the 
complexity of factors involved in cell communication and growth. However, growth arrest and 
consequent metabolic activity inhibition are a consistent issue in 3D matrices added to the 
fact that cells are spatially constrained and need to overcome the environment impediments 
to populate the surrounding environment [138].  
Regarding these issues, the morphology of CCD18-Co cells under 2D culture conditions 
was evaluated to further on compare with the cell morphology in 3D culture conditions. After 
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7 days were observed remarkable differences between cells densities, highlighting the 
elongated cell shape only at the density 1×104 cells/cm2 (Fig. 4. 4 A). Cell morphology 
suffered abrupt alterations beyond 1×104 cells/cm2 cell density, result of the contact 
inhibition and the lack of space. Between 5×104 cells/cm2 and 10×104 cells/cm2, cells adopted 
a starry-like morphology, still mixed with some elongated cells (Fig. 4. 4 B and C). For the 
density of 1×105 cells/cm2, the population of cells with the characteristic fibroblast shape was 
found on odd occasion. Distinctly, at the highest density (20×104 cells/cm2), CCD18-Co cells 
presented a skinny cell body with some cells overlapping in some regions (Fig. 4. 4 D). 
At 14 days, the previous scenario is aggravated but 1×104 cells/cm2 cell density seems 
to be the better adequate density presenting a good spatial organization and maintained the 
original and characteristic morphology of myofibroblasts(Fig. 4. 5 A). At higher densities (D2 
and D3), the starry-like population of fibroblasts is more prominent (Fig. 4. 5 B) observing the 
existence of a syncytium at D3 (Fig. 4. 5 C), a multinucleated cell that can result from 
multiple cell fusions of mononuclear cells. The existence of a syncytium is reported in the in 
vivo intestinal mucosa where subepithelial fibroblasts merge with other stromal cells in the 
lamina propria, for instance, interstitial fibroblasts and pericytes [48]. Besides not completely 
inadequate, this situation is not healthy to the cells. At D4, CCD18-Co cells continue to adopt 
an elongated shape with a slender cell body, but with a more mature and evolved shape (Fig. 
4. 5 D). 
After 21 days, 1×104 cells/cm2 seems to be the healthier and well adapted cell density 
to a period time of 21 days (Fig. 4. 6 A), in detriment to the starry-like shape observed at 
higher densities (Fig. 4. 6 B-D). Until now, most of the assays were concordant in elect 1×104 
cells/cm2 as the cell density better adapted to 21 days of culture. To further characterize the 
3D morphology of CCD18-Co and the surrounding matrix was adopted the lowest cell density 
of 1×104 cells/cm2. 
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 7th day 
 
 
 
 
 
  
 Figure 4. 4. Intestinal fibroblasts morphology identified by vimentin staining at day 7. After 7 days, are already notable differences in cells morphology.  At D2 and D3, cells 
acquired a starry-like shape result of contact inhibition and lack of space. At D4, CCD18-Co cells presented skinny cell bodies noticing some cells overlapping. Vimentin was labelled 
with AlexaFluor488 (green) and a nucleus was labelled with DAPI (blue). Scale indicates 50 μm. (A) 1x104 cells/cm2, (B) 5x104 cells/cm2, (C) 10x104 cells/cm2 and (D) 20x104 cells/cm2. 
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14th day 
 
 
 
 
  
Figure 4. 5. Intestinal fibroblasts morphology identified by vimentin staining at day 14. The scenario is aggravated and, so far, D1 revealed the healthier cell density. The starry-
like population is more prominent at higher densities (D2 and D3), observing the presence of multinucleated cells at D3. Vimentin was labelled with AlexaFluor488 (green) and a 
nucleus was labelled with DAPI (blue). Scale indicates 50 μm. (A) 1x104 cells/cm2, (B) 5x104 cells/cm2, (C) 10x104 cells/cm2 and (D) 20x104 cells/cm2. 
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 21st day 
 
 
 
 
 
   
Figure 4. 6.Intestinal fibroblasts morphology identified by vimentin staining at day 21. After 21 days, D1 seems to be the well adapted density for 2D culture conditions observed by 
the distended cell shape and in detriment of the cell morphology at higher cell densities (D2, D3 and D4). Vimentin was labelled with AlexaFluor488 (green) and a nucleus was labelled 
with DAPI (blue). Scale indicates 50 μm. (A) 1x104 cells/cm2, (B) 5x104 cells/cm2, (C) 10x104 cells/cm2 and (D) 20x104 cells/cm2. 
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4.1.5. Characterization of ECM components 
 
Fibroblasts signaling can substantially differ depending on whether the cells are in 3D 
or 2D culture conditions. The matrigel matrix affected cell metabolic activity and 
proliferation, as previously observed by resazurin assay and dsDNA quantification. Also, cell 
morphology was found to be susceptible to the 3D matrix constrictions. Additionaly, 
fibroblasts are specialized cells in the remodeling of ECM and fibronectin (FN) is one of the 
components associated with biological processes involved in that remodeling [137]. FN 
characterization was thus performed over 21 days, simultaneously staining the intermediate 
filaments of CCD18-Co cells using vimentin to observe the changes in cell morphology in 3D 
conditions. 
As can be observed in Fig. 4. 7 A, the FN staining after 7 days was condensed to small 
dots. After 14 days, the outcome was a more complex and concrete staining uniquely 
produced by CCD18-Co cells (Fig. 4. 7 B). At day 21, the levels of FN expression seemed not 
to be altered when compared with day 14 (Fig. 4. 7 C). 
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Figure 4. 7. Characterization of fibronectin network of CCD18-Co cells cultured in 2D standard conditions. Over 
21 days, is observed a shy increase of FN expression. (A) At day 7 the FN is limited to condensed small dots, but 
after 14 days (B), it starts to reveal a more concrete staining. (C) At day 21, the levels of FN expression are 
maintained with similar complexity compared with day 14. Fibronectin was labelled with AlexaFluor 488 (green), 
vimentin AlexaFluor 594 (red) and nucleus with DAPI (blue). Scale indicates of 50 μm. 
 
Regarding the FN expression in 3D conditions, was observed that after 7 days CCD18-Co 
cells revealed a complex network of FN (Fig. 4. 8 A). Even though manufactures report the 
detection of trace amounts of FN by Western Blot [139], matrigel is from rat origin [140] and 
FN expression was assessed with a human antibody to only assess the FN produced by CCD18-
Co cells. Overall, matrigel seems to act as an initial livelihood that maintains the 3D 
rearrangement of fibroblasts while they are not producing their own ECM components. After 
14 days, the FN expression was similar to the first 7 days (Fig. 4. 8 B). At this point, probably 
most of the existent matrigel was completely substituted by ECM components produced by 
CCD18-Co cells. To confirm this, further studies are required namely compare the expression 
of FN of rat origin and human origin. No relevant images were obtained for the 21 days. 
Nonetheless, CCD18-Co cells showed to be evenly distributed throughout the matrigel 
matrix confirming that 1×104 cells/cm2 was the cell density better adapted to both 2D and 3D 
culture conditions. Usually, there is no correlation between 2D and 3D mechanisms, but, in 
this specific case, it was established for cell density. As soon as matrigel polymerization was 
completed, matrigel thickness was significantly reduced. After 21 days under the effect of 
CCD18-Co cells and environmental factors, matrigel content was probably substituted in the 
totality. In fact, matrigel not only contains basement membrane components (laminins, 
collagen IV and heparin sulphate proteoglycans) but also matrix degrading enzymes (MMP-2 
and MMP-9) and growth factors (EGF, bFGF, NGF, PDGF, TGF-β) [141]. Even though the rate of 
matrigel degradation is not reported, MMPs are vital to the degradation of both basement 
membrane and stromal matrices. Gelatinases MMP-2 and MMP-9 and transmembrane MMPs are 
critical mediators of basement membrane remodelling [142]. Therefore, even though the 
matrigel degradation rate is not reported, it integrity is compromised by plenty of 
environmental factors that will obey the system to react and produce ECM components. 
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In spite the cell density has been the same for 2D and 3D culture conditions, the cell 
morphology showed to be quite distinct. When CCD18-Co cells are cultured in a 3D Matrigel 
matrix (Fig. 4. 8 A and B), they appeared elongated but spindle-shaped. This characteristic 
morphology was already observed in cell-derived 3D matrices [137]. Compared with the cells 
seeded on a 2D surface at the same density (1×104 cells/cm2), these ones possesses a 
characteristic fan-shaped lamellae.  
 
 
 
Figure 4. 8. Characterization of fibronectin network of CCD18-Co cells cultured in 3D conditions. (A) After 7 
days CCD18-Co cells embedded in Matrigel® revealed a complex network of fibronectin comparable to day 14 (B). 
The 3D distribution of CCD18-Co cells seems well adapted to the matrix microenvironment. Fibronectin was 
labelled with AlexaFluor 488 (green), vimentin AlexaFluor 594 (red) and nucleus with DAPI (blue). Scale indicates 
50 μm. 
 
Overall, CCD18-Co cells in 2D culture condition were broader and more flattened, 
presenting more cell protrusions than in the 3D matrices, tendency already observed by 
Hakkinen K. et al. [128]. 
 
4.1.6. Topographical features of CCD18-Co cells 
 
The topographic features of the membrane were further visualized by SEM. After 21 
days, CCD18-Co cells showed to populate the entire film as observed in Fig. 4. 9 A, however, 
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their elongated morphology do not fill all the spaces allowing a freer permeation. In the 
detached image of Fig. 4. 9 A, are represented the hole spaces between CCD18-Co cells 
acquired throughout the capture of retrodifused electrons instead of the standard secondary 
electrons. This acquisition delineates the regions of higher atomic number, appearing brighter 
[143]. In this case, the brighter regions represent the glass coverslip, translated in open 
spaces for freely permeation of a compound.  
On the other hand, CCD18-Co cells seeded onto matrigel previously coated Transwell 
inserts revealed a complex network composed by ECM components (Fig. 4. 9 B) in contrast 
with fibroblasts seeded on the coverslip (Fig. 20). In certain regions was possible to observe 
the porous of the membrane since CCD18-Co cells are not completely opaque. 
In one case or in the other, the disposition and morphology of CCD18-Co cells forms a 
cell monolayer with unoccupied spaces that allow a freer permeation. 
 
 
 
Figure 4. 9. Scanning electron micrographs of the CCD18-Co and Matrigel/CCD18-Co monolayer. (A) CCD18-Co 
monolayer in a coverslip showed to populate the entire film. Scale indicates 400 μm. (B) CCD18-Co cells seeded on 
Matrigel coated Transwell insert revealed a more complex network composed by ECM components.  Scale indicates 
40 μm. 
 
 
4.2 Barrier modulation by epithelial cells 
 
A characteristic feature of epithelial cells is the formation of cell junctions resulting in 
a tight cellular barrier that selectively controls the diffusion along the paracellular way, 
namely the TJs [144]. An intact barrier is crucial for the biological activities of a tissue but 
also for reliable in vitro experiments. 
 
4.2.1 Assessing barrier integrity 
 
A quantitative measure of integrity and maturity of a monolayer is the electric 
resistance of the cell layer [145]. Caco-2 cells are tighter linked by TJs, underestimating the 
paracellular permeability of compounds transported by this route. As result, Caco-2 cells are 
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characterized by high TEER values comprised between 150-1600 Ω.cm2.  This wide range is 
proof of the high inter-laboratory variability result of different culture conditions such as 
seeding density, passage number, days in culture, among others factors [87]. 
As observed in Fig. 4. 10, TEER measurements of the Caco-2 model presented higher 
values compared with the other models. In opposition, CCD18-Co model presented the lowest 
TEER values compared with the other models, what is justified by their morphological 
features that did not form a tight monolayer. The influence of matrigel coating with respect 
to the resistance values was not conclusive. Upon the introduction of CCD18-Co cells in direct 
contact with Caco-2 epithelial cells, TEER values presented a significant decrease. It may 
happen that CCD18-Co cells are interspaced between Caco-2 cells, interfering with the 
barrier tightness. 
Were tested two distinct 3D configurations in which CCD18-Co cells are in different 
assemblies. As depicted in Fig. 4. 10, 3D co-cultures (CCD18-Co/Matrigel/Caco-2 and CCD18-
Co+Matrigel/Caco-2) presented a slower rate of growth and significant lower TEER values over 
the 21 days when compared with 2D models. The CCD18-Co+Matrigel/Caco-2 model resulted 
in lower TEER values due to the fact that CCD18-Co cells dispersed in matrigel were not as 
proliferative as in 2D standard conditions, as observed before in the proliferative assays.  
Despite this, this model reached a desirable integrity above 200 Ω.cm2 [146] and since this 
configuration closely mimics the cell-cell and cell-matrix interactions found in the intestinal 
mucosa, was proceeded with this configuration for further studies. Notwithstanding, the 
model CCD18-Co/Matrigel/Caco-2 represents an interesting configuration to study the in vivo 
deposition of ECM components by stromal that will form the supportive basement membrane 
[147]. 
 
 
Figure 4. 10. TEER cell measurements monitored in function of time during 21 days of culture in cell based 
models of CCD18-Co intestinal fibroblasts and Caco-2 cells. Caco-2 monolayer was the model with higher TEER 
values in contrast with the CCD18-Co model. Results are the average of replicates and bars represent the standard 
deviation (n=4). 
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4.2.2. Epithelial-stromal interactions  
 
In the sequence of the previous results, it was confirmed that the matrigel matrix 
influenced the metabolic activity and proliferation of CCD18-Co cells in 3D conditions. 
To also clarify the interaction between stromal and epithelial cells, it was 
characterized the proliferative behaviour of CCD18-co cells and Caco-2 cells in direct contact 
after 7 days on a plastic substrate (Fig. 4. 11 A). Other control situations were tested as 
depicted in Fig. 4. 11 B - F. 
 
  
Figure 4. 11. Effect of the substrate on cell proliferation of Caco-2 and CCD18-Co cells after 7 days of culture. 
(A) Epithelial and stromal co-culture seeded onto a plastic substrate. (B) Stromal cell monoculture of CDD18-Co 
cells seeded on a plastic substrate. (C) Stromal monoculture of CCD18-Co cells seeded on a matrigel-coated plate. 
(D) Stromal cell monoculture of CDD18-Co cells embedded in a Matrigel® matrix. (E) Epithelial cell monoculture of 
Caco-2 seeded on plastic substrate. (F) Epithelial cell monoculture of Caco-2 seeded on a matrigel-coated plate. (G) 
CCD18-Co cells were less proliferative when entrapped in the Matrigel® matrix compared with plastic. In contrast, 
Caco-2 cells were significantly more proliferative when seeded onto a matrigel-coated substrate. Results are the 
average of replicates and bars represent the standard deviation (n=3). The statistical differences (p<0.05) are 
denoted by (*). 
 
After 7 days of growth, the cell number was determined and compared to the initial 
cell number. As observed in Fig. 4. 11 G, stromal cells were proliferative on plastic but 
showed reduced proliferation when embedded in matrigel. This reinforces that the 
entrapment of CCD18-Co cells in a matrigel matrix limits the cell proliferation, due to the 
matrix constraints and the hypoxia environment. Moreover, the process of entrapment 
requires multiple pipetting steps to suspend a cell suspension in the matrigel matrix and that 
may lead to some shear-induced damage. In contrast, CCD18-Co cells seeded onto a matrigel 
coated plate showed to be proliferative. In turn, Caco-2 cells showed identical proliferation 
when seeded onto a plastic surface with no significant differences comparing with the initial 
cell seeding, but significantly higher proliferation was observed when seeded onto matrigel 
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coated plates. These results were expected considering that matrigel is rich in ECM 
components that constitute an excellent substrate for cell growth and proliferation [148].  
Taking advantage of the fact that CCD18-Co cells presented a proliferative behaviour in 
the plastic substrate, it was explored the effect CCD18-Co when in direct contact with Caco-2 
cells. It was observed a high proliferative activity compared to the initial cell density, 
concluding that CCD18-Co cells did not inhibit the proliferation of Caco-2 cells and that both 
cell types had a synergetic effect when coated in direct contact. 
 
4.2.3. Topographical features of Caco-2 cells 
 
As observed in Fig. 4. 12, after 21 days, an uniform and differentiated character of 
Caco-2 epithelial cells was revealed by the presence of the typical microvilli, reported to be 
between 0.5-1.5 μm in length and 0.1 μm in width, varying according the species [149]. The 
boundary of cells is circumvented by a denser join of microvilli at the boundaries of two cells.  
 
 
Figure 4. 12. Scanning electron micropraphs of the Caco-2 monolayer after 21 days of culture. The presence 
of microvilli is the most characteristic feature of Caco-2 cells. Scale indicates 20 μm and 10 μm. 
 
4.2.4. Expression of tight junctions proteins 
 
Epithelial barrier function is regulated in large part by the apical intercellular junctions, 
referred to as the TJs, which comprises transmembrane proteins (occludin, claudin and 
junctional adhesion molecule (JAM)) and cytoplasmatic proteins (zonnula occludens ZO-1, ZO-
2, ZO-3 and cingulin) [150]. TJs form a continuous barrier between epithelial cells, which 
create tissue spaces and regulate the movement of solutes across the epithelium. The 
formation of a tight monolayer is a determinant factor to an in vitro model which application 
aims to test the absorption/permeation of a compound.   
All the epithelial cells possess one common characteristic of express TJ proteins and form 
TJs between each other [144]. For instance, current evidences indicate that claudins play a 
central role in defining electrical resistance and permselectivity [151].  
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As observed in Fig. 4. 13 A-C, the top scanning of Caco-2 monolayer demonstrated a 
homogeneous ring along the perimeter of the cells confirming that Caco-2 cells formed tight 
and adherent junctions that limited the passage of components and confirm the functional 
properties of the barrier. This tendency had been already noticed by the TEER measurements, 
which returned high values of resistance. 
 
   
Figure 4. 13. Expression of claudin-5, occludin and E-cadherin in Caco-2 cell monolayer. (A) Claudin-5, (B) 
Occludin and (C) E-Cadherin. The top scanning of Caco-2 monolayer demonstrated a homogeneous ring along the 
perimeter of the cells, confirming the tight character of Caco-2 monolayer. Claudin-5 and E-Cadherin were labelled 
with AlexaFluor488 (green), occludin with AlexaFluor594 (red) and nucleus with DAPI (blue). Scale indicates 20 μm. 
 
4.2.5. Caco-2 / HT29-MTX co-culture model 
 
The introduction of new cell lines somehow interfere with the tighter character of the 
Caco-2 monolayer, but at the same time approximate the TEER values from the human 
intestine, ranging from 12-69 Ω.cm2 [79, 102]. The introduction of HT29-MTX in the model 
interferes with the barrier formation as these cells will be interspersed between Caco-2 cells 
altering the tighter character of the Caco-2 monolayer. Even though both cells types establish 
TJ between each other, they present a structural variability facilitating the passage of ions by 
paracellular pathway [144].  
The less tight character of the co-culture of Caco-2 and HT29-MTX cells was confirmed 
by the measurement of the TEER (Fig. 4. 14). The Caco-2/HT29-MTX monolayer presented a 
gradual increase of TEER values during 21 days but significantly lower when compared with 
the Caco-2 monolayer. The 3D triple model (CCD18-Co+Matrigel/Caco-2/HT29-MTX cells) 
revealed a decrease in TEER values compared with the previous 3D double model (CCD18-
Co+Matrigel/Caco-2) result of the introduction of HT29-MTX cells. 
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Figure 4. 14. TEER cell measurements monitored in function of time during 21 days of culture in a cell based 
model of CCD18-Co intestinal fibroblasts, Caco-2 and HT29-MTX cells. Caco-2/HT29-MTX model presented lower 
TEER values compared with Caco-2 model regarding the less tight character of tight junctions between both cell 
types. Results are the average of replicates and bars represent the standard deviation (n=4). 
 
In Fig. 4. 15 A, it is depicted the expression of a tight junction protein claudin-5 
between HT29-MTX cells, observing the rounder shape distinct from Caco-2 cells. When in co-
cultured, Caco-2 cells and HT29-MTX cells also express a tight junction protein occludin (Fig. 
4. 15 B), being impossible to discriminate Caco-2 cells from HT29-MTX by similar shape and 
size [77]. 
 
  
Figure 4. 15. Expression of claudin-5 in HT29-MTX monolayer and occludin in Caco-2/HT29-MTX monolayer. 
Despite the different structure of tight junctions of HT29-MTX cells, Caco-2/HT29-MTX monolayer expressed a strong 
staining for occludin tight junction protein.   Claudin-5 was labelled with AlexaFluor488 (green), occludin with 
AlexaFluor594 (red) and nucleus with DAPI (blue). Scale indicates 20 μm. 
 
In contrast, it was possible to distinct Caco-2 from HT29-MTX cells by transmission 
electron microscopy. As observed in Fig. 4. 16 A, the monolayer is richly covered by mucin-
filled granules, which tend to coalescence, a process in which two or more elements merge to 
form a single element. The Caco-2 epithelial cells formed microvilli on their apical surface 
exhibiting slight variability in density along the different regions of the monolayer. HT29-MTX 
cells were distinguished by the presence of intracellular granules, appearance similar to in 
vivo goblet cells that contain mucin granules located below the apical membrane [152]. As 
depicted in Fig. 4. 16 B, both epithelial Caco-2 and HT29-MTX cells were able to form tight 
junctions. 
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Figure 4. 16. Transmission electron micrographs of Caco-2/HT29-MTX monolayer. (A) Caco-2/HT29-MTX 
monolayer with typical microvilli and mucin granules. Scale bar indicates 0.5 μm. The black arrows represent 
indications of coalescence. (B) Tight junction formed between Caco-2 (left) and HT29-MTX cell (right). Scale 
indicates 0.5 μm. The fold is an artefact of specimen preparation procedure for TEM. 
 
4.2.6. Evidence of M-like cell formation 
 
M cells, located in the epithelia overlying mucosa-associated lymphoid tissues (i.e. 
PPs), are an instrument in initiating mucosal immunity and a portal for the delivery of 
macromolecules and microorganisms, consequently explored to antigen delivery [76]. The 
little known about the interactions between M cells and enterocytes and between M cells 
makes difficult their unambiguous identification. Claudin-1/3 and ZO-1 were detected in the 
TJs of both M cells and enterocytes within mouse intestinal follicles-associated epithelium 
(FAE) revealing the contact of M cells with the adjacent cells through TJs.  Regarding AJs 
between M cells of mouse PPs, they revealed enhanced expression of β-catenin, α-actinin, 
polymerized actin and in some areas, E-cadherin, differing from enterocytes [153]. 
Furthermore, M cells appear to exhibit an increased depth and an altered rearrangement of 
TJ strands differing from the non-FAE intestinal epithelia [154]. 
TJs rearrangement between enterocytes and M cells is somehow reproduced in vitro by 
the conversion of Caco-2 epithelial cells into M-like cells by Raji B lymphocytes [36]. It was 
expected that the TEER values of Caco-2/Raji B model presented similar values to the Caco-2 
model since this model is mainly comprised by Caco-2 cells. However, it was observed a 
decrease in TEER values compared with Caco-2 model that can be result of the conversion of 
Caco-2 cells into M-like cells. This seems to be a remote idea since M-like cells were 
originated from Caco-2 cells, which upon the introduction of Raji B cells (day 15), already 
form a very tight monolayer. Even though this evidence was already reported [106], is 
necessary to confirm this assumption by identifying the soluble factors responsible for this 
phenotypic induction and TJ strength. 
The triple model of Caco-2/HT29-MTX/Raji B cells presented lower TEER values when 
compared with the Caco-2/Raji B control result of the presence of HT29-MTX cells. The 3D 
quadruple model (CCD18-Co+Matrigel/Caco-2/HT29-MTX/Raji B) presented a slower increase 
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of TEER values with a similar profile to the 3D triple model (CCD18-Co+Matrigel/Caco-2/HT29-
MTX). 
 
 
Figure 4. 17. TEER cell measurements monitored in function of time during 21 days of culture in a cell based 
model of CCD18-Co intestinal fibroblasts, Caco-2 cells, HT29-MTX and Raji B cells. Caco-2/Raji B model 
presented high TEER values, in the same range of the TEER values of Caco-2 model. Results are the average of 
replicates and bars represent the standard deviation (n=4). 
 
In Fig. 4. 18, is possible to visualize that the triple model of Caco-2, HT29-MTX and M-
like cells is tight enough despite the structural differences between the epithelial cells.. The 
top scanning of co-culture monolayer demonstrates a homogeneous ring around the perimeter 
of the cells, morphologically identical despite the heterogeneous cell population. 
 
 
Figure 4. 18. Expression of tight junction protein occludin in Caco-2/HT29-MTX/Raji B model. Despite the 
structural differences between epithelial cells, the triple model revealed a tight character. Occludin was labelled 
with AlexaFluor594 (red) and a nucleus was labelled with DAPI (blue). Scale indicates 20 μm. 
 
4.2.6.1. Quantification of alkaline phosphatase activity 
 
Morphologically distinct from enterocytes, M cells display poorly organized brush border 
with short irregular microvilli at the apical domain. As result, the enzymatic activity of 
alkaline phosphatase is down-regulated [8]. In vitro studies showed that lymphocytes trigger 
the conversion of enterocytes cell lines into M-like cells in co-culture under influence of 
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membrane-bound lymphotoxin (LTα1β2) secreted by B-lymphocytes [36]. Therefore, the 
presence of Raji B lymphocytes in the basolateral side is known to protagonize the M-cell 
formation [106-108]. 
Alkaline phosphatase (ALP) is as an excellent marker of crypt-villus differentiation, 
since ALP of Caco-2 cells have identical sequence [155] and similar biochemical 
characteristics [156] compared to the intestinal alkaline phosphatase (IAP) isoenzyme, which 
is exclusively expressed in villi enterocytes [157]. 
In order to trigger M-like cell formation, an alkaline phosphatase assay based on a work 
of Ferruza et al. [123], was performed as mean to monitor the down-regulation in the alkaline 
phosphatase activity. As observed in Fig. 4. 19, the ALP activity increased over the 21 days of 
culture, although not significantly between days 14 and 21 (period of contact with Raji B 
cells), what reveals that these assay was not significantly sensitive enough to trigger the 
presence of M-like cells. The gradual increase of ALP activity was already been observed in 
Caco-2 monolayer [123, 158]. Nonetheless, this quantitative assay was never applied to study 
the down-regulation of ALP in M-like cells and the down-regulation of ALP activity was only 
observed in in vivo studies. There are qualitative evidences of the decrease of ALP activity in 
a triple co-culture of Caco-2/HT29-MTX/Raji B when compared with the control of Caco-
2/HT29-MTX [108], however further evidences are required. Moreover, it was not studied the 
amount of M-like cells formed regarding the initial Raji B cell density. This is certainly a 
hypothesis to explore, in order to equalize the in vitro cell number of M-like cells to the in 
vivo proportions of M cells.  
 
 
Figure 4. 19. Alkaline phosphatase (ALP) activity during differentiation of Caco-2/Raji B model. ALP activity 
increased over the 21 days of culture revealing that this method was not sensitive enough to detect the presence 
of M-like cells. Results are the average of replicates and bars represent the standard deviation (n=3). The 
statistical differences (p<0.05) are denoted by (*). 
 
4.2.6.2. Morphological features of M-like cells 
 
HT29-MTX cells display more sparse microvilli [77], what could enter in conflict with 
the identification of M-like cells. Opportunely, HT29-MTX cells contain intracellular mucin 
granules that allowed the identification of HT29-MTX cell by transmission electron 
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microscopy. As observed in Fig. 4. 20 A, after 21 days some HT29-MTX cells are found closer 
to the basal side of Caco-2 cells. In fact, HT29-MTX present a doubling time different from 
Caco-2 cells, the last with higher doubling time [106]. Notwithstanding, are still observed 
mucin-filled granules at the epithelial monolayer (Fig. 4. 20 B) which shows that, although 
not pictured, some HT29-MTX cells are near the apical side of Caco-2 cells, releasing some 
mucin granules that remain adsorbed to the apical membrane. Hilgendorf et al. had already 
noticed that the standard composition of Caco-2 cell medium did not favored the HT29-MTX 
growing, leading to co-cultures that were more similar to Caco-2 monocultures than mixed 
cultures [105]. 
Once again, Caco-2 cells displayed slight variability in microvilli density along of the 
different regions of the monolayer. This variability did not allow the undoubted confirmation 
of the presence of M-like cells. Nonetheless, epithelial cells are tightly linked each other 
constituting an evident barrier to the drug translocation (Fig. 4. 20 B). 
 
 
Figure 4. 20. Transmission electron micrographs of Caco-2/HT29-MTX/Raji B monolayer. (A) HT29-MTX cells 
with intracellular mucin-filled granules sited over the Transwell filter. Scale indicates 1 μm. (B) Tight junctions 
formed between epithelial cells with typical microvilli and some mucin granules. Scale indicates 1 μm. The fold is 
an artefact of specimen preparation procedure for TEM. 
 
Nevertheless, M-like cells were possibility identified by scanning electron microscopy 
by the lack of microvilli interspersed between Caco-2 cells (Fig. 4. 21 A). It was not possible 
to distinguish Caco-2 cells from HT29-MTX cells by their morphological features but residual 
evidences of mucus seem to be retained over the surface of microvilli (Fig. 4. 21 B). 
However, this did not preclude the presence of an uninterrupted layer of mucus covering the 
epithelial layer, as reported by other authors in the same proportions of Caco-2 and HT29-
MTX cells [118]. Probably, most of the mucus was lost during the membrane processing for 
scanning electron microscopy. 
Overall, SEM allowed to observe a more representative area to the identification of M-
like cells while TEM was more effective in the identification of HT29-MTX cells and presence 
of mucin-filled granules. 
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Figure 4. 21. Scanning electron micrographs of the Caco-2/Raji B double model and of the Caco-2/HT29-
MTX/Raji B triple model after 21 days. (A) M-like cells are identified by shorther or lack of microvilli in the Caco-
2/Raji B model. (B) HT29-MTX cells were not distinguished from Caco-2 cells but there are evidences of mucus 
attached. The cracking is an artefact of specimen preparation procedure for SEM. Scale bar of 50 μm and 40 μm. 
 
4.2.7. Visualization of the tridimensional model 
 
As observed in Fig. 4. 22 A, Caco-2 cells presented their characteristic columnar shape. 
After three weeks of culture, a dense monolayer of epithelial cells was maintained over a gel 
layer of CCD18-Co fibroblasts embedded in matrigel (Fig. 4. 22 B). This organization is 
somewhat like the native small intestinal mucosa in with the epithelial cells lying onto a 
lamina propria (Fig. 4. 22 C) [111]. In fact, the initial thickness of the matrigel was lost but 
their degradation allowed the CCD18-Co cells to easier populate the 3D matrix. Therefore, 
CCD18-Co cells had an active role in the construction of lamina propria that sustains epithelial 
cells. The elongated morphology of CCD18-Co cells in a 3D matrix seems to indicate that 
CCD18-Co cells were able to modulate the matrix, otherwise would appear less elongated.  
 
 
 
  
  
Figure 4. 22. Tridimensional model visualization through histological cut stained with H&E. (A) Caco-2 
monolayer showing the characteristic columnar shape of Caco-2 cells. The colouration below the Transwell insert is 
an artefact of the histological staining. (B) In vivo cut of the in vivo small intestinal mucosa. (C) CCD18-Co intestinal 
fibroblasts embedded in matrigel sustain Caco-2 cells over them. Scale indicates 20 μm. 
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Then, the matrix that sustains the epithelial cells was characterized by staining 
fibronectin. As observed in Fig. 4. 23, the FN expression was restricted to the fibroblastic 
layer that sustains the Caco-2 monolayer. Some fibroblasts were able to cross the 3 μm 
Transwell insert, evidenced by the presence of residual staining above the filter. This result is 
an evidence of the active role of CCD18-Co cells, as they were able of reformulate the 
matrigel and leave the matrix. 
 
 
Figure 4. 23. Fibronectin expression of a paraffin section of tridimensional model of CCD18-Co cells 
embedded in Matrigel and Caco-2 cells. FN is restricted to the fibroblastic layer of CCD18-Co cells demonstrating 
the supportive role of CCD18-Co cells in maintain epithelial cell layer.  Fibronectin was labelled with AlexaFluor 
488 (green) and nucleus with DAPI (blue). Scale indicates 10 μm. 
 
4.2.8.  Insulin permeability 
 
The functional character of the model was validated comparing the permeability profile 
of insulin in the monocultures and co-cultures of CCD18-Co, Caco-2, HT29-MTX and Raji B 
cells. The choice of insulin as a model drug supported by the previous experience of the 
group. 
Besides the controversial character of the absorption mechanism of oral administrated 
insulin, the paracellular pathway is the most feasible pathway for its passage across the 
intestinal epithelium due to its high hydrophilicity [15]. Moreover, since insulin (isoelectric 
point ≈ 5.4) is negatively charged at the pH of the small intestine, it interaction with 
negatively charged mucins at the epithelial surface will repulse insulin avoiding it to reach 
the cells [159, 160]. In contrast, morpho-cytochemical and biochemical evidences in both 
normal and diabetic rats studied the ileal tissues and between 2 and 5 minutes, insulin 
labeling was associated to the microvilli and endocytic vesicles in the apical portion of 
epithelial cells. At 10 minutes, insulin labeling was found at the level of the trans-side of 
Golgi apparatus and along the basolateral membranes of epithelial cells [161, 162]. 
Importantly, insulin has been reported to be absorbed into the rat ileal epithelium in the 
presence of permeation enhancers and protease inhibitors [162], but in addition, an insulin-
degrading enzyme (IDE) has been identified in the cytosol of the rat intestinal enterocytes 
constituting up to 92% of total insulin-degrading activity [163]. Moreover, insulin receptors, 
that have been identified in the basolateral membranes of dog intestinal mucosa [164], in 
mouse intestinal cells [165] and in the membrane of Caco-2 cells [166], may be functional in 
the protein transport across the intestinal epithelium but their precise role remains unclear. 
 RESULTS & DISCUSSION 
 
62 
 
Thus, both pathways are feasible to transport insulin. However, the endossomal degradation 
and the insulin-degrading enzyme neglect the real contribution of the transcellular pathway 
in the transport of insulin. 
 
Permeability studies were performed with insulin in free-form over 4 hours with 
parallel measurement of TEER values. Before the experiment, the cultures were equilibrated 
with HBSS and TEER values were allowed to stabilize. The intrinsic resistance of the cell layer 
is influenced by the cell culture medium in the apical and basolateral compartment, by the 
membrane of the filter inserts and by the electrode-medium interface. Since transport 
experiments are performed in HBSS, TEER values typically decreased in result of the 
adjustment of the experiment conditions.  
As depicted in Fig. 4. 24, all the models showed the same profile in the TEER 
measurement, reaching an almost stationary profile after 1 hour of experiment. As the 
compound interacts with the cell layer, TEER values usually decrease resulting in the opening 
of TJs. That decrease is returned as soon as the culture conditions are reestablished as 
proved by higher values of FITC-Dextran permeation and reported by other authors [167, 
168].   
 
 
 
Figure 4. 24. TEER values monitored in function of time during 4 hours of permeability experiments, 
comprising Caco-2, CCD18-Co cells, HT29-MTX and Raji B cells. All models revealed a significant decrease in 
TEER values.  Despite the decrease, Caco-2 model presented the higher TEER values after 4 hours. Results are the 
average of replicates and bars represent the standard deviation (n=3). 
 
4.2.8.1. Insulin quantification 
 
The permeability profile of all the models follows a similar tendency during the time of 
the experiment translated in an increased permeability with a decrease of TEER values (Fig. 
4. 25).  
Caco-2 monoculture presented the lower amount of permeated insulin, expected by the 
higher TEER values and the tighter junctions. Noticeably, as higher the initial TEER values, 
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the profile of decrease of resistance values during the permeability experiment seems to 
decrease quicker and more accentually, with exception of the monolayer co-culture of 
CCD18-Co and Caco-2 cells. In contrast, CCD18-Co and Matrigel/CCD18-Co monolayer allowed 
the higher permeation to the passage of insulin without meaningful variations after 30 
minutes (Fig. 4. 25). The effect of matrigel coating is not perceived in TEER values, but 
becomes more noticeable that matrigel coating seems to interfere with the permeability 
studies, limiting the transport of insulin to the basolateral side. This observation is justified 
by the proliferative behaviour of CCD18-Co cells when seeded on a matrigel substrate. The 
permeability profile of the CCD18-Co/Caco-2 model was similar to the Caco-2 model, since 
both cells co-exist in co-culture as observed by their proliferative character. 
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Figure 4. 25. Cumulative transport of insulin across monocultures and co-cultures of CCD18-Co and Caco-2 
cells. CCCD18-Co model is the one presenting higher permeation to insulin regarding the high pore size of CCD18-
Co monolayer. Results are the mean of replicates and bars represent the standard deviation (n=3). 
 
The apparent permeability coefficient (Papp) represents a cumulative amount of the test 
compound in the basolateral side, not distinguishing the contribution of each transport 
pathway. The Papp value to insulin in Caco-2 monolayers was higher 1×10
-6 cm/s but, as 
expected, presented the lower Papp compared with the other models (Table 4. 1). Moreover, 
Papp values of CCD18-Co/Caco-2 model were not significantly different of Caco-2 model, 
recalling the similarity of TEER values with the Caco-2 model. CCD18-Co cell seeded onto 
matrigel coating presented significantly lower Papp compared with the Papp of CCD18-Co 
monolayer. As observed before by scanning electron microscopy, CCD18-Co seeded onto 
matrigel presented a complex matrix that can offer more resistance to the transport of 
insulin (Fig. 4.9 B). Comparing both 3D configurations, the 3D double model CCD18-
Co+Matrigel/Caco-2 allowed a higher permeation of insulin when compared with the CCD18-
Co/Matrigel/Caco-2. Besides the less proliferative character of CCD18-Co cells when 
embedded in matrigel, the 3D assembly seems to be a critical factor in the transport of 
insulin. 
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Table 4. 1. Apparent permeability coefficient (Papp × 10
-6 cm/s) of insulin across the monolayer comprising Caco-
2 and CCD18-Co cells. Results are the mean of three replicates ± standard deviation (n=3, mean ± SD). 
 
In vitro models Papp (× 10
-6 cm/s) Significance level 
CCD18-Co 6.03 ± 0.23 
(***) 
Matrigel/CCD18-Co 3.95 ± 0.74 
   
Caco-2 2.77 ± 0.18 
(ns) 
CCD18-Co/Caco-2 3.00 ± 0.08 
   
CCD18-Co +Matrigel/Caco-2 4.76 ± 0.08 
(**) 
CCD18-Co/Matrigel/Caco-2 3.96 ± 0.19 
 
As stated before, the introduction of mucus-producing cells interferes with the barrier 
tightness. These results showed that HT29-MTX cells were involved in the increase of 
permeability of insulin (Fig. 4. 26). In the in vivo scenario, mucus interaction with the 
negative charges of insulin difficult their entrapment by the mucus, however, in static 
conditions the mucus may approximate the insulin molecules near of the epithelial surface, 
retaining a considerable amount that will permeate through the less strait TJ between both 
epithelial Caco-2 and HT29-MTX cell lines. Therefore, the existence of mucus was propitious 
to the transport of insulin, effect already reported by Jin et al. [169].   
 
 
Figure 4. 26. Cumulative transport of insulin across monocultures and co-cultures of CCD18-Co fibroblasts, 
Caco-2 cells and HT29-MTX cells. Caco-2/HT29 model presented higher permeation to insulin compared to the 
Caco-2 model control, revealing that the existence of mucus was propitious to the transport of insulin. Results are 
the mean of three replicates and bars represent the standard deviation (n=3, mean ± SD). 
 
Comparing the Caco-2/HT29-MTX model with the Caco-2 control, the double model 
presented higher susceptibility to the permeation of insulin favored by the presence of mucus 
and the less tight junctions between both Caco-2 and HT29-MTX epithelial cells. As expected, 
the 3D triple model (CCD18-Co+Matrigel/Caco-2/HT29-MTX) showed relative higher 
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permeation compared with the 3D double model (CCD18-Co+Matrigel/Caco-2) result of the 
presence of HT29-MTX cells (Table 4. 2). As argued before, the 3D models allowed a higher 
permeation of insulin justified by entrapment of CCD18-Co cells in the matrigel matrix.   
 
Table 4. 2. Apparent permeability coefficient (Papp × 10
-6 cm/s) of insulin across the models comprising CCD18-
Co, Caco-2 and HT29-MTX cells. Results are the mean of three replicates ± standard deviation (n=3, mean ± SD). 
 
In vitro models Papp (× 10
-6 cm/s) Significance level 
Caco-2 2.77 ± 0.18 
*** 
Caco-2/HT29-MTX 6.32 ± 0.18 
 
CCD18-Co + Matrigel/Caco-2 4.76 ± 0.08 
** 
CCD18-Co + Matrigel/Caco-2/HT29-MTX 7.42 ± 0.28 
 
M cells are characterized by their high transcytotic capacity and reduced expression of 
enzymatic activity throughout the down-regulation of alkaline-phosphatase and sucrase 
enzymes present in microvilli [8]. Even though the in vitro presence of M-like cells has been 
progressively revealed [106, 108], detailed information lacks regarding the permeability 
behaviour of the models comprising these cells.  
In the results depicted in Fig. 4. 27, seems that the presence of M-like cells increased 
the permeability of insulin. In fact, it remains the question whether, upon Raji B cells 
conversion, there is any change in TJ structure that would justify an increase in permeability. 
If there is a loss of the tightness of the monolayer due to the presence of M-like cells, that 
would favor the paracellular route. More remotely, insulin can also take advantage of the 
transcytotic capacity of M-like cells.  
 
 
Figure 4. 27. Cumulative transport of insulin across monocultures and co-cultures of CCD18-Co fibroblasts, 
Caco-2 cells, HT29-MTX and Raji B cells. (A) Caco-2/Raji B model presented lower permeation to insulin 
compared to the CCD18-Co+Matrigel ®/Caco-2/HT29-MTX/Raji B model (B), mainly result of the introduction of 
HT29-MTX cells. Results are the mean of three replicates and bars represent the standard deviation (n=3, mean ± 
SD). 
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Comparing the Papp values, it is evident that the presence of M-like cells favored the 
transport of insulin.  The 3D quadruple model (CCD18-Co+Matrigel/Caco-2/HT29-MTX/Raji B 
cells) represents the model that allows the more freely permeation of insulin (Table 4. 3). 
 
Table 4. 3. Apparent permeability coefficient (Papp × 10
-6 cm/s) of insulin across the monolayer comprising 
CCD18-Co, Caco-2, HT29-MTX cells and Raji B lymphocytes. Results are the mean of three replicates ± standard 
deviation (n=3, mean ± SD). 
 
In vitro models Papp (× 10
-6 cm/s) Significance level 
Caco-2 2.77 ± 0.18 
*** 
Caco-2/Raji B 5.51 ± 0.34 
   
CCD18-Co + Matrigel/Caco-2/HT29-MTX 7.42 ± 0.28 
ns 
CCD18-Co + Matrigel/Caco-2/HT29-MTX/Raji B 8.82 ± 0.98 
 
Comparing all the 3D models, both Papp values of CCD18-Co+Matrigel/Caco-2/HT29-MTX 
and CCD18-Co+Matrigel/Caco-2/HT29-MTX/Raji B models were significantly different from 
CCD18-Co+Matrigel/Caco-2 model revealing that the introduction of HT29-MTX cells was a 
critical factor in the permeability of insulin (Fig. 4. 28). In contrast, the Papp values of CCD18-
Co+Matrigel/Caco-2/HT29-MTX and CCD18-Co+Matrigel/Caco-2/HT29-MTX/Raji B models were 
not significantly different but was observed an increase of Papp result of the presence of M-
like cells. 
Overall, the non proliferative character of CCD18-Co cells embedded in matrigel is a 
critical factor for the barrier formation. All the 3D models showed higher permeation 
compared with the respective monolayer of control. In static conditions, the presence of 
mucus and the less tight character between the epithelial cells contributed to the increase of 
insulin permeability. Arguably, there is a remote chance of insulin take advantage of M-like 
cells transcytotic capacity. It also remains the question whether the M-like cells formation 
alter the tight character of Caco-2 cell monolayer. 
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Figure 4. 28. Apparent permeability coefficient (Papp) of insulin through the tridimensional models comprising 
CCD18-Co, Caco-2 cells, HT29-MTX cells and Raji B cells. The 3D quadruple model presented the one with higher 
permeation to insulin. Significant differences were analysed regarding the CCD18-Co+Matrigel®/Caco-2 model. 
Results are the mean of three replicates and bars represent the standard deviation (n=3, mean ± SD); (*) denotes a 
significant decrease (p<0.05). 
 
Besides the low TEER values of the in vivo intestinal tissue, there are a plenty of other 
barriers that limit the absorption of the luminal content and justify the higher ex vivo Papp 
values. For instance, the drastic pH changes, the enzymatic activity, the presence of efflux 
transporters are not usually replicated in standard cell culture [56].  
It is worth to mention that despite the high variability between the permeability 
studies of different laboratories, our date is correlated with several ex vivo data (Table 4. 4). 
When compared the Papp values of the 3D quadruple model with the Papp of ex vivo data, was 
concluded that the 3D quadruple model was efficient in predicting insulin permeability. 
 
Table 4. 4. Apparent permeability coefficient (Papp × 10
-6 cm/s) of insulin across rat ileum ex vivo models. 
Results are the mean of three replicates ± standard deviation (n=3, mean ± SD). 
 
Ex vivo tissue Papp (×10
-6cm/s) Reference 
Ileum 0.90 ± 0.10 [170] 
Ileum 0.55 ± 0.06 [171] 
Jejunun 0.60 ± 0.02 [171] 
Jejunun 7.35 ± 1.18  [172] 
 
4.2.8.2. FITC-Dextran permeation 
 
After permeability studies, the integrity of the membrane was assessed by permeating 
a 4 kDa small fluorescent molecule that follows the paracellular route of transport to 
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transverse the epithelial layer. FITC-Dextran crosses the cell layer through passive 
paracellular transport being a good indicative of the integrity of the membrane [173]. As 
observed in Fig. 4. 29, after the drug transport assays, all of the models retained the FITC-
Dextran above 70%, with exception of CCD18-Co monolayer. The percentage of rejection 
regards the amount of molecule that the barrier retains in the apical side. This integrity 
studies showed that insulin had not negative repercussions in the membrane and that the 
tight junctions opening was reversible. 
 
A B 
 
 
                                        C 
 
Figure 4. 29. 4 kDa FITC-Dextran permeability after 4 hours of permeability studies to assess the membrane 
integrity. Results are the mean of three replicates ± standard deviation (n=3, mean ± SD). 
 
Overall, the 3D quadruple model comprising CCD18-Co intestinal myofibroblasts, Caco-
2, HT29-MTX and M-like epithelial cells was morphologically and functionally characterized. 
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 The herein work is motivated in satisfy the current needs of the drug development 
field. ‘Petri-dish’-based models are limiting the potential of predict cellular responses of real 
organisms as they do not replicate the architecture and the mechanisms representative of a 
living tissue. Based on the Caco-2 gold standard model, we launched the challenge of create a 
third dimension that could bridge the gap between cell culture models and live intestinal 
tissues. In this sense, a 3D co-culture model comprising CCD18-Co intestinal myofibroblasts, 
Caco-2, HT29-MTX and Raji B cells was established. Beyond the fact that Caco-2 cells 
resembles the main features of enterocytes, this model is valued by the presence of HT29-
MTX mucus producing cells in the same proportions found in vivo and M-like cells, an 
important player in the process of drug absorption owing a high transcytotic capacity. 
Moreover, the scenario of interdependency between stromal and epithelial cells was 
evaluated as mean to dissect their role in the barrier formation. 
 By exploring the behaviour of CCD18-Co cells in a 3D matrix through cell viability, 
metabolic activity, proliferation and morphological assays, 1×104 cells/cm2 showed to be the 
cell density better adapted for 21 days of culture, period necessary to fully differentiate the 
Caco-2 cells. Added to that, CCD18-Co cells proved to be active in the modulation the 
surrounding Matrigel matrix through the production of fibronectin. This newly-formed matrix 
exerts a supportive role in the maintenance of the epithelial cells onto CCD18-Co cells. This 
event was the bottom line to establish a 3D model that resembles the native mucosa. 
The barrier functionality is essential for purposes of absorption or permeation studies. 
The formation of a tightly-knit monolayer between all the cell types is determinant for the 
validation of results in permeability assays. Caco-2 cells form a tight polarized monolayer 
resulting in the highest TEER values. Even though Caco-2 and HT29-MTX cells establish tight 
junctions between each other, they present structural variability, resulting in a decrease of 
TEER values. Regarding the interactions between M-like cells and the Caco-2 and HT29-MTX 
cells, little is known. But the models comprising M-like cells registered a decrease in TEER 
values, which was probably due to the transformation of phenotype of Caco-2 cells into cells 
with M-phenotype. Nonetheless, this assumption requires further studies namely the 
identification soluble factors responsible for the phenotype induction and TJ strength. 
Discriminate Caco-2 and HT29-MTX cells is difficult due to their similar morphology. 
Notwithstanding, HT29-MTX cells were distinctly identified by transmission electron 
microscopy (TEM) exhibiting the intracellular presence of mucin granules.  Evidences of 
mucin-filled granules were found to richly cover the epithelial surface. Morphologically 
distinct from enterocytes, M cells display poorly organized brush border with short irregular 
microvilli. Even though trigger M-like cells have revealing a challenge because of the 
inexistence of a distinct cell marker, the lack of microvilli was still the best cue to identify 
these cells. Alkaline phosphatase is an excellent marker of crypt-villus differentiation, since 
ALP of Caco-2 cells have identical sequence and similar biochemical characteristics compared 
to the intestinal alkaline phosphatase (IAP). M cells exhibit down-regulation of alkaline 
phosphatase activity. However, there are no in vitro evidences of down-regulation of this 
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enzyme upon the phenotypic transformation. Therefore, the sensitivity of ALP assay to trigger 
the existence of M-like cells is doubtful and further assays are required.  
The utmost importance of this work points to the sustainable results that the present 
model returned, supporting the successfully establishment of a barrier model reliable for the 
study of drug permeability. The 3D quadruple model (CCD18-Co+Matrigel/Caco-2/HT29-
MTX/Raji B) was efficient in the prediction of insulin permeability when compared with 
several ex vivo models. Overall, the less tight character between the epithelial cells, the 
presence of mucus and M-like cells were determinant factors in the transport of insulin.  
After 4 hours of permeability studies, 4 kDa FITC-Dextran molecule was retained on its 
majority by the barrier models, with exception of CCD18-Co monocultures, revealing that 
tight junctions opening was reversible and insulin did not have negative repercussions on the 
model integrity.  
Finally, as future perspectives is imperative to understand how to control the 
thickness of the fibroblastic layer and quantify the amount of other ECM components. 
Concerning the variety of epithelial cells, it is also necessary to assess the final proportion of 
all the cell types in culture and understand how the presence of other epithelial cells (HT29-
MTX and M-like cells) can influence Caco-2 cells differentiation. The mechanisms by which 
insulin cross the Caco-2/Raji B models are not fully understood. It remains to explore the TJ 
strength between Caco-2 and M-like cells and the contribution of the transcytotic route 
through M-like cells in the transport of insulin. To accomplish the undoubtful identification of 
M-like cells will be explored other cell markers. With this, we will be able to understand how 
the initial cell density of Raji B cells affects the amount of M-like cells. Finally, is necessary 
to test a higher number of compounds with different BCS properties and correlate these 
results with in vivo experiments.  
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